<SEC-DOCUMENT>0001628280-21-006255.txt : 20210331
<SEC-HEADER>0001628280-21-006255.hdr.sgml : 20210331
<ACCEPTANCE-DATETIME>20210331161133
ACCESSION NUMBER:		0001628280-21-006255
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20210331
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210331
DATE AS OF CHANGE:		20210331

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ROCKWELL MEDICAL, INC.
		CENTRAL INDEX KEY:			0001041024
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				383317208
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23661
		FILM NUMBER:		21793404

	BUSINESS ADDRESS:	
		STREET 1:		30142 WIXOM ROAD
		CITY:			WIXOM
		STATE:			MI
		ZIP:			48393
		BUSINESS PHONE:		8004493353

	MAIL ADDRESS:	
		STREET 1:		30142 WIXOM ROAD
		CITY:			WIXOM
		STATE:			MI
		ZIP:			48393

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ROCKWELL MEDICAL TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20120530

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ROCKWELL MEDICAL, INC.
		DATE OF NAME CHANGE:	20120525

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ROCKWELL MEDICAL TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19970722
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>rmti-20210331.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:f945e035-252a-4ea6-acd4-1e709520a8d5,g:3405d109-d668-4000-83c6-500821b09bc6,d:be2e6ea9b3544eb485fe0e6424e71df2--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>rmti-20210331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl80L2ZyYWc6OGMyZjFjMjgxNThkNDgxNWIwYmEzMDQ3ZGRmYzYzMDkvdGFibGU6YjY5YTI0OTVlY2NiNGZkZTkzZDk0MDkzYTI5NTEzYzIvdGFibGVyYW5nZTpiNjlhMjQ5NWVjY2I0ZmRlOTNkOTQwOTNhMjk1MTNjMl8xLTEtMS0xLTA_7709aed5-fb43-43cc-89f3-ce4ffd45333e">0001041024</ix:nonNumeric><ix:nonNumeric contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl80L2ZyYWc6OGMyZjFjMjgxNThkNDgxNWIwYmEzMDQ3ZGRmYzYzMDkvdGFibGU6YjY5YTI0OTVlY2NiNGZkZTkzZDk0MDkzYTI5NTEzYzIvdGFibGVyYW5nZTpiNjlhMjQ5NWVjY2I0ZmRlOTNkOTQwOTNhMjk1MTNjMl8yLTEtMS0xLTA_555c5d13-3afb-4e54-a76f-65b314d111c0">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="rmti-20210331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001041024</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-31</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ibe2e6ea9b3544eb485fe0e6424e71df2_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGV4dHJlZ2lvbjo3ZDM3M2MxYzQyNDE0MjVhYTY0MmQ1ZTAwYmI2YzBjNl8yNjM2_84c2bc01-6867-481a-bf2b-1c859f4ae089">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d)&#160;of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">the Securities Exchange Act of 1934</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;<ix:nonNumeric contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGV4dHJlZ2lvbjo3ZDM3M2MxYzQyNDE0MjVhYTY0MmQ1ZTAwYmI2YzBjNl8yMzc_2f19c88c-a8cf-4b5d-9900-6123e2a70a7d">March 31, 2021</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGV4dHJlZ2lvbjo3ZDM3M2MxYzQyNDE0MjVhYTY0MmQ1ZTAwYmI2YzBjNl8yNjMx_05ce7b0d-d246-4e72-b223-58613458bed0">ROCKWELL MEDICAL,&#160;INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.064%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGFibGU6NmY2OGIxMjQwNzdhNGVmMGJiZmM1N2ExMzg3MDkwMzIvdGFibGVyYW5nZTo2ZjY4YjEyNDA3N2E0ZWYwYmJmYzU3YTEzODcwOTAzMl8wLTAtMS0xLTA_cb00a963-537e-4736-a2e5-12f1e9070463">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGFibGU6NmY2OGIxMjQwNzdhNGVmMGJiZmM1N2ExMzg3MDkwMzIvdGFibGVyYW5nZTo2ZjY4YjEyNDA3N2E0ZWYwYmJmYzU3YTEzODcwOTAzMl8wLTEtMS0xLTA_ab00d533-5157-41f5-a0c3-14941fbe264f">000-23661</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGFibGU6NmY2OGIxMjQwNzdhNGVmMGJiZmM1N2ExMzg3MDkwMzIvdGFibGVyYW5nZTo2ZjY4YjEyNDA3N2E0ZWYwYmJmYzU3YTEzODcwOTAzMl8wLTItMS0xLTA_6fe8d4ab-1d81-4013-b7de-dce859879dae">38-3317208</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction<br/>of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGV4dHJlZ2lvbjo3ZDM3M2MxYzQyNDE0MjVhYTY0MmQ1ZTAwYmI2YzBjNl8yNjMy_613cbb4c-1fff-4ccf-986d-1a1b2106c20a">30142 S. Wixom Avenue</ix:nonNumeric>, <ix:nonNumeric contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGV4dHJlZ2lvbjo3ZDM3M2MxYzQyNDE0MjVhYTY0MmQ1ZTAwYmI2YzBjNl8yNjI3_1d69d2be-482b-4618-839f-e4a7d9a8db76">Wixom</ix:nonNumeric>, <ix:nonNumeric contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGV4dHJlZ2lvbjo3ZDM3M2MxYzQyNDE0MjVhYTY0MmQ1ZTAwYmI2YzBjNl8yNjI1_83b639df-2290-4318-9fde-62e5258d7116">Michigan</ix:nonNumeric> <ix:nonNumeric contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGV4dHJlZ2lvbjo3ZDM3M2MxYzQyNDE0MjVhYTY0MmQ1ZTAwYmI2YzBjNl8yNjI4_d9c98528-ec0a-4d89-b59b-c142e45457dc">48393</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGV4dHJlZ2lvbjo3ZDM3M2MxYzQyNDE0MjVhYTY0MmQ1ZTAwYmI2YzBjNl8yNjI5_be9072bb-46dd-485f-a53f-2fa9dab8abe9">248</ix:nonNumeric>) <ix:nonNumeric contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGV4dHJlZ2lvbjo3ZDM3M2MxYzQyNDE0MjVhYTY0MmQ1ZTAwYmI2YzBjNl8yNjM3_cbd0da74-6cc5-4e8e-836e-1df8063b841d">960-9009</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:454.50pt"><tr><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:427.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGFibGU6MGM5MTgyMDY3OGNiNDdkNjk3NGVmZjRkMTU4MGJiMTcvdGFibGVyYW5nZTowYzkxODIwNjc4Y2I0N2Q2OTc0ZWZmNGQxNTgwYmIxN18wLTEtMS0xLTA_37b425ca-8f5c-4cfb-8ff1-a284ea98f645">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:454.50pt"><tr><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:427.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGFibGU6MTIzNmYzYjc3YzVlNGVlNzkxZDZmN2EwMWJkNTAwZmQvdGFibGVyYW5nZToxMjM2ZjNiNzdjNWU0ZWU3OTFkNmY3YTAxYmQ1MDBmZF8wLTEtMS0xLTA_e7c74183-a0cb-4eaa-9c99-8b7b0c961117">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:484.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGFibGU6NjMxZmEwMWU3MWNjNDQ1NmExZmFiNThiMTFkZGE2NDMvdGFibGVyYW5nZTo2MzFmYTAxZTcxY2M0NDU2YTFmYWI1OGIxMWRkYTY0M18wLTEtMS0xLTA_5bbeb185-891b-4fe2-a259-6ad61244bd8e">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:484.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGFibGU6MjQ5M2E5YmFmYzgxNDI5MWExZWNmNjA4MTgxYTM0OGUvdGFibGVyYW5nZToyNDkzYTliYWZjODE0MjkxYTFlY2Y2MDgxODFhMzQ4ZV8wLTEtMS0xLTA_ae914c1e-c6fe-4e13-b0c6-24647df4e58d">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:33.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.507%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title&#160;of&#160;Each&#160;Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading&#160;Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name&#160;of&#160;Each&#160;exchange&#160;on&#160;which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGFibGU6NzRjMTZjOTUzYThmNDY2NGJhNDBjZGEyNzczMzVjNmEvdGFibGVyYW5nZTo3NGMxNmM5NTNhOGY0NjY0YmE0MGNkYTI3NzMzNWM2YV8xLTAtMS0xLTA_ff86f458-7f83-4678-8fb3-03d36cd27003">Common Stock, par value $0.0001</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGFibGU6NzRjMTZjOTUzYThmNDY2NGJhNDBjZGEyNzczMzVjNmEvdGFibGVyYW5nZTo3NGMxNmM5NTNhOGY0NjY0YmE0MGNkYTI3NzMzNWM2YV8xLTItMS0xLTA_5a202a31-c98e-4447-922f-e406a2dee93b">RMTI</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGFibGU6NzRjMTZjOTUzYThmNDY2NGJhNDBjZGEyNzczMzVjNmEvdGFibGVyYW5nZTo3NGMxNmM5NTNhOGY0NjY0YmE0MGNkYTI3NzMzNWM2YV8xLTQtMS0xLTA_ef23835b-6c23-4fb6-b70f-0c9ee0c3f3c0">Nasdaq Global Market</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGV4dHJlZ2lvbjo3ZDM3M2MxYzQyNDE0MjVhYTY0MmQ1ZTAwYmI2YzBjNl8yNjM1_17a20442-2f43-4afb-90a3-3504d9bc5e19">&#9744;</ix:nonNumeric> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;2.02</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Results of Operations and Financial Condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On March 31, 2021, Rockwell Medical, Inc. issued a press release and earnings presentation announcing its financial results for the quarter and year ended December 31, 2020. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8&#8209;K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;9.01</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Financial Statements and Exhibits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;Exhibits&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The following exhibit is being furnished herewith:</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT&#160;INDEX</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:8.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.081%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="rmti-202012312020xearnings.htm">Press Release, dated March 31, 2021</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File, formatted in INline XBRL and included as Exhibit 101.</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SIGNATURE</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.261%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ROCKWELL MEDICAL,&#160;INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;Russell Ellison</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Russell Ellison</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>rmti-202012312020xearnings.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i86afa34a4d7945c58032a691c673a99f_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><img alt="image_01.jpg" src="image_01.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:239px"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:125%">Rockwell Medical Provides Fourth Quarter and Full Year 2020 Financial and Operational Update                                   </font></div><div><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">- 2020 revenue of $62.2 million-</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">-Ended the year with $58.7 million in cash, cash equivalents and investments &#8211;</font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font><br></font></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">-Conference call and webcast on Wednesday, March 31</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> at 4&#58;30 p.m. ET-</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WIXOM, Mich., March 31, 2021 (GLOBE NEWSWIRE) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-- Rockwell Medical, Inc. (Nasdaq&#58; RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today reported financial results and a business update for the three months and full year ended December 31, 2020. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">&#8220;2020 was an important year for us as we evolved our strategy to become a more medically-,  scientifically- and data-driven company. There has been an evolution of both our management and Board, providing us with greater relevant experience,&#8221; said Russell Ellison, M.D., M.Sc., President and Chief Executive Officer of Rockwell Medical. &#8220;We believe these changes support an improved execution of our strategy to accelerate Rockwell Medical&#8217;s growth by creating and developing pharmaceutical products based on our Ferric Pyrophosphate Citrate (&#34;FPC&#34;) technology for disease states where patients can benefit the most from an effective treatment for iron deficiency, while concurrently strengthening our dialysis business to drive incremental growth and efficiencies.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dr. Ellison added&#58; &#8220;We&#8217;ve identified two areas beyond dialysis where we believe FPC will have the biggest impact&#58; iron deficiency anemia in the home infusion setting and acute heart failure in hospitalized patients.&#8221;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Recent</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Operational Highlights</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Dialysis Business</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.03pt">Revenue from hemodialysis concentrates were $61.1 million in 2020.</font></div><div style="margin-bottom:0.08pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%;padding-left:12.03pt">Revenue from Triferic were approximately $1.1 million in 2020.</font></div><div style="margin-bottom:0.08pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%;padding-left:12.03pt">Results from a study, conducted by New York University and reported in Critical Care Medicine, showed $296,000 in cost savings from Triferic.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">The study, which was independent of Rockwell, reviewed the effects of long-term use of Triferic in a large outpatient dialysis clinic. The results showed substantial cost savings due to reductions in ESA and macromolecular IV iron use without impacting patient safety or hemoglobin targets.  In a retrospective data review of 100 patients that were followed before and after implementation of Triferic dialysate, there was a relative </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><img alt="image_01.jpg" src="image_01.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:239px"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">reduction in average weekly ESA dose of 26.4%, total use of IV iron replacement therapy decreased with a relative reduction in the use of all iron products (iron sucrose 65.7%, sodium ferric gluconate 98.2%) while anemia targets were met. This clinic determined that the reduction of these agents resulted in a net savings of more than $296,000 in one fiscal year.</font></div><div style="margin-bottom:0.08pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%;padding-left:12.03pt">Triferic AVNU (ferric pyrophosphate citrate injection), the IV formulation of Triferic, was made commercially available to patients in the United States.</font></div><div style="margin-bottom:0.08pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%;padding-left:12.03pt">Korea&#58; In September 2020, Rockwell Medical partnered with Jeil Pharmaceutical Co., Ltd. for exclusive rights. In February 2021, Jeil filed a New Drug Application for Triferic (dialysate) and Triferic AVNU in Korea.</font></div><div style="margin-bottom:0.08pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%;padding-left:12.03pt">China&#58; In January 2021, Wanbang Biopharmaceuticals enrolled the first patient in a pivotal Phase 3 trial.</font></div><div style="margin-bottom:0.08pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%;padding-left:12.03pt">India&#58; In January 2020, Rockwell Medical and Sun Pharma entered into a licensing agreement, and Sun Pharma is in the regulatory process in India.</font></div><div style="margin-bottom:0.08pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%;padding-left:12.03pt">Canada&#58; In May 2020, Rockwell Medical announced the filing of a New Drug Submission with Health Canada for Triferic AVNU.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Home Infusion Program</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.03pt">The U.S. Food and Drug Administration (FDA) has accepted our proposed development strategy to pursue an approval via the 505(b)(1) pathway as a novel new drug application (NDA) for FPC for treatment of iron deficiency anemia (IDA) in adult patients in the home infusion setting. Subsequent to a successful pre-investigational new drug meeting with the FDA, the Company plans to initiate a clinical study during the second half of 2021. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Pipeline Development</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.03pt">Rockwell Medical is exploring the use of its FPC platform for the treatment of hospitalized patients with acute heart failure.  Management believes that FPC may deliver rapidly bioavailable iron to the heart and improve cardiac energetics. This effect could help patients recover faster, resulting in shorter hospital stays and fewer 30-day re-admissions. The Company plans to hold a Type C meeting with the FDA in the second half of 2021. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">2020 Corporate Updates</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.03pt">In December 2020, Rockwell Medical appointed industry leader and renowned life science industry executive, Ms. Andrea Heslin Smiley, to its Board of Directors. Ms. Smiley brings commercial experience and a deep expertise in clinical nurse educators.  </font></div><div style="padding-left:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><img alt="image_01.jpg" src="image_01.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:239px"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.03pt">In September 2020, the Company appointed Russell L. Skibsted, M.B.A., as Executive Vice President, Chief Financial Officer and Chief Business Officer. Mr. Skibsted brings more than 25 years of experience in finance, global business development, capital raising, investor relations and operations. </font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.03pt">In June 2020, Rockwell Medical appointed industry leader and renowned authority on kidney disease, Allen R. Nissenson, M.D., F.A.C.P., to its Board of Directors. Dr. Nissenson brings clinical, regulatory and public policy expertise, combined with his senior executive experience at a large dialysis organization.    </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.03pt">In April 2020, the Company appointed Russell H. Ellison, M.D., M.Sc., as President and Chief Executive Officer. Dr. Ellison, who continues to serve as a member of the Rockwell Medical Board of Directors, brings broad medical, clinical development and corporate leadership experience to the role.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.03pt">In March 2020, Rockwell Medical appointed Robert S. Radie to its Board of Directors. Mr. Radie brings more than three decades of industry experience, working in senior executive roles with both public and private pharmaceutical and biotech companies.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fourth Quarter and Full Year 2020 Selected Financial Highlights</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis should be read in conjunction with our audited condensed consolidated financial statements and related notes</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">on Form 10-K for the year ended December 31, 2020. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Revenues were $15.2 million and $62.2 million for the three months and year ended December 31, 2020, respectively, compared to $15.5 million and $61.3 million for the three months and year ended December 31, 2019, respectively.  Triferic revenue was $0.5 million and $1.1 million for the three months and year ended December 31, 2020, respectively. Triferic was launched in Q2 2019 via the sample evaluation program.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cost of sales were $14.8 million and $59.5 million for the three months and year ended December 31, 2020, respectively, compared to $14.4 million and $58.5 million for the three months and year ended December 31, 2019, respectively. Cost of sales for the year ended December 31, 2020 resulted in gross profit of $2.7 million, compared to a gross profit of $2.8 million for the year ended December 31, 2019.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Research and product development expenses were $1.9 million and $7.1 million for the three months and year ended December 31, 2020, respectively, compared to $2.0 million and $6.9 million for the three months and year ended December 31, 2019, respectively. The increase of $0.2 million year over year is related to clinical trials and other product development expenses for Triferic. The Company is continuing to invest in its medical and scientific programs to support the continued data and phase 4 clinical programs for Triferic in dialysis and the advancement of our FPC technology platform. </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><img alt="image_01.jpg" src="image_01.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:239px"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Selling and marketing expenses were $2.1 million and $7.9 million for the three months and year ended December 31, 2020, respectively, compared to $1.9 million and $9.1 million for the three months and year ended December 31, 2019, respectively. The decrease of $1.2 million year over year is due primarily to the decrease in marketing costs of $2.3 million, partially offset by an increase in costs associated with hiring, training and educating new employees of $1.1 million. The fluctuation in these costs is mainly due to the timing of the Triferic (dialysate) launch in the third quarter of 2019. We expect lower quarter-to-quarter fluctuations in sales and marketing costs going forward.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">General and administrative expenses were $4.4 million and $16.2 million for the three months and year ended December 31, 2020, respectively, compared to $4.7 million and $21.0 for the three months and year ended December 31, 2019, respectively.  The $4.8 million decrease year over year was driven primarily by decreases to stock compensation, legal, recruiting and consulting fees, partially offset by an increase in labor costs. The decrease in stock compensation primarily relates to the resignation of our former President and Chief Executive Officer, Stuart Paul, in April 2020 and former Chief Financial Officer effective July 2020.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Net loss was $8.7 million, or $(0.09) basic and diluted net loss per share, and $30.9 million, or $(0.41) basic and diluted net loss per share, for the three months and year ended December 31, 2020, respectively, compared to net loss of $7.3 million, or $(0.11) basic and diluted net loss per share, and $34.1 million, or $(0.56) basic and diluted net loss per share, for the three months and year ended December 31, 2019, respectively.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cash, cash equivalents, and investments available-for-sale totaled $58.7 million as of December 31, 2020, compared to $67.3 million on September 30, 2020. Working capital was $56.7 million as of December 31, 2020, compared to $65.2 million as of September 30, 2020. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company has a debt facility of $35.0 million of which the first tranche of $22.5 million was funded in March 2020 and is classified as long-term debt on the balance sheet. The Company may be eligible to draw on a third tranche of $7.5 million upon the achievement of certain additional milestones, including the achievement of certain Triferic sales thresholds. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As of December 31, 2020, there were 93,573,165 shares of common stock outstanding.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fourth Quarter and Full Year 2020 and Business Update Conference Call and Webcast</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Rockwell Medical's management team will host a conference call and audio webcast today, March 31, 2021, at 4&#58;30 p.m. ET to discuss Q4 and Full Year 2020 financial results and provide a business update.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To access the conference call, please dial (877) 383-7438 (local) or (678) 894-3975 (international) at least 10 minutes prior to the start time and refer to conference ID 6154055. A live webcast of the call will be available under &#34;Events &#38; Presentations&#34; in the Investor section of the Company's website, https&#58;&#47;&#47;ir.rockwellmed.com&#47;. An archived webcast will be available </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><img alt="image_01.jpg" src="image_01.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:239px"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">on the Company's website approximately two hours after the event and will be available for 30 days.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About Triferic Dialysate and Triferic AVNU</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Triferic Dialysate and Triferic AVNU are the only FDA-approved therapies in the U.S. indicated to replace iron and maintain hemoglobin in hemodialysis patients during each dialysis treatment. Triferic Dialysate and Triferic AVNU have a unique and differentiated mechanism of action, which has the potential to benefit patients and health care economics. Triferic Dialysate and Triferic AVNU represent a potential innovative medical advancement in hemodialysis patient iron management &#8211; with the potential to become the future standard of care.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Triferic Dialysate and Triferic AVNU both deliver approximately 5-7 mg iron with every hemodialysis treatment to replace the ongoing losses to maintain hemoglobin without increasing iron stores. Both formulations donate iron immediately and completely to transferrin (carrier of iron in the body), which is then transported to the bone marrow to be incorporated into hemoglobin. Because of this unique mechanism of action, there is no increase in ferritin (a measure of stored iron). Triferic and Triferic AVNU address a significant medical need in treating functional iron deficiency in end-stage kidney disease patients.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The safety profile of Triferic is similar to placebo in controlled clinical trials in patients with end-stage kidney disease. Since approval, there have been no safety related changes to the product labeling.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IMPORTANT SAFETY INFORMATION FOR TRIFERIC AND TRIFERIC AVNU</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">INDICATION</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">TRIFERIC and TRIFERIC AVNU are indicated for the replacement of iron to maintain hemoglobin in adult patients with hemodialysis-dependent chronic kidney disease (HDD-CKD).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Limitations of Use</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">TRIFERIC and TRIFERIC AVNU are not intended for use in patients receiving peritoneal dialysis. TRIFERIC and TRIFERIC AVNU have not been studied in patients receiving home hemodialysis.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Warnings and Precautions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Serious hypersensitivity reactions, including anaphylactic-type reactions, some of which have been life-threatening and fatal, have been reported in patients receiving parenteral iron products. Patients may present with shock, clinically significant hypotension, loss of consciousness, and&#47;or collapse. Monitor patients for signs and symptoms of hypersensitivity during and after hemodialysis until clinically stable. Personnel and therapies should be immediately available for the treatment of serious hypersensitivity reactions. Hypersensitivity </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><img alt="image_01.jpg" src="image_01.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:239px"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">reactions have been reported in 1 (0.3%) of 292 patients receiving TRIFERIC in two randomized clinical trials.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Iron status should be determined on pre-dialysis blood samples. Post-dialysis serum iron parameters may overestimate serum iron and transferrin saturation.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Adverse Reactions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Most common adverse reactions (incidence &#8805;3% and at least 1% greater than placebo) in controlled clinical studies include&#58; headache, peripheral edema, asthenia, AV fistula thrombosis, urinary tract infection, AV fistula site hemorrhage, pyrexia, fatigue, procedural hypotension, muscle spasms, pain in extremity, back pain, and dyspnea.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To report an Adverse Events (AE) or Product Quality Control (PQC) please call the Medical Information Department at (855) 333-4315 or e-mail at </font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">rockwell.pharmacovigilance&#64;propharmagroup.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For full Safety and Prescribing Information please visit </font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">www.Triferic.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">www.Trifericavnu.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About Rockwell Medical </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Rockwell Medical is a biopharmaceutical company dedicated to transforming iron deficiency and anemia management in a wide variety of therapeutic areas and across the globe, improving the lives of very sick patients. The Company&#8217;s initial focus is the treatment of anemia in end-stage kidney disease. Rockwell Medical's exclusive renal drug therapies, Triferic (ferric pyrophosphate citrate) Dialysate and Triferic AVNU, are the only FDA-approved therapeutics indicated for maintenance of hemoglobin in hemodialysis patients. Rockwell Medical is also an established manufacturer, supplier and leader in delivering high-quality hemodialysis concentrates&#47;dialysates to dialysis providers and distributors in the U.S. and abroad.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Forward-Looking Statements </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Certain statements in this press release may constitute &#8220;forward-looking statements&#8221; within the meaning of the federal securities laws, including, but not limited to, the effectiveness of FPC in other indications, Triferic&#8217;s ability to generate cost savings, our ability to grow our dialysis business, the development plans and timing for Rockwell Medical&#8217;s FPC pipeline candidates, the timing and outcome of meetings with the FDA, the timing and outcome of foreign clinical trials and regulatory approval, the timing for the commencement of our clinical trial of FPC for treatment of IDA in adult patients in the home infusion setting and future trends related to our sales and marketing costs. Words such as, &#8220;may,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;can,&#8221; &#8220;would,&#8221; &#8220;develop,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;forecast,&#8221; &#8220;project,&#8221; &#8220;intend&#8221; and similar expressions, or statements regarding intent, belief, or current expectations, are forward looking statements.  While Rockwell Medical believes these forward-looking statements are reasonable, undue reliance should not be placed </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><img alt="image_01.jpg" src="image_01.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:239px"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:115%">on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties (including, without limitation, those set forth in Rockwell Medical&#8217;s SEC filings), many of which are beyond our control and subject to change. Actual results could be materially different.  Risks and uncertainties include, but are not limited to&#58; the continuance of the COVID-19 pandemic (including, applicable federal state or local orders) on business and operating results, including our supply chain, dialysis concentrates business and the Company&#8217;s commercialization of both pharmaceutical and medical device products&#59; the challenges inherent in new product development,  other new indications and therapeutics areas for our products&#59; the success of our commercialization of Triferic (dialysate) and Triferic AVNU&#59; the success and timing of international clinical trials for Triferic Dialysate&#59; the success and timing of international regulatory and reimbursement approval for Triferic (dialysate) and Triferic AVNU&#59; the  success of our commercial launch of Triferic AVNU in the United States&#59; the success and timing of the development of our FPC pipeline candidates, the risk that topline clinical data and real world data results may not demonstrate efficacy or may not be predictive of future results&#59;  expected financial performance, including cash flows, revenues, growth, margins, funding, liquidity and capital resources&#59; and those risks more fully discussed in the &#8220;Risk Factors&#8221; section of our Annual Report on Form 10-K for the year ended December 31, 2020, as such description may be amended or updated in any future reports we file with the SEC. Rockwell Medical expressly disclaims any obligation to update our forward-looking statements, except as may be required by law. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:107%">Triferic&#174; is a registered trademark of Rockwell Medical, Inc. Triferic AVNU is pending with the U.S. Patent and Trademark Office. All other product names, logos, and brands are property of their respective owners in the United States and&#47;or other countries. All company, product and service names used on this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Financial Tables Follow</font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><img alt="image_01.jpg" src="image_01.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:239px"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ROCKWELL MEDICAL, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Dollars in Thousands)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</font></div><div><font><br></font></div><div style="text-align:center"><img alt="image2.jpg" src="image2.jpg" style="height:637px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><img alt="image_01.jpg" src="image_01.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:239px"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ROCKWELL MEDICAL, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Dollars in Thousands, except per share amounts)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><img alt="image1.jpg" src="image1.jpg" style="height:373px;margin-bottom:5pt;vertical-align:text-bottom;width:675px"></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">###</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONTACTS </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Investors&#58;</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Argot Partners</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">212.600.1902</font></div><div><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Rockwell&#64;argotpartners.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Media&#58;</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">David Rosen</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Argot Partners</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">212.600.1902</font></div><div><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">david.rosen&#64;argotpartners.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>rmti-20210331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:f945e035-252a-4ea6-acd4-1e709520a8d5,g:3405d109-d668-4000-83c6-500821b09bc6-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rmti="http://rockwellmed.com/20210331" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://rockwellmed.com/20210331">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rmti-20210331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rmti-20210331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rmti-20210331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rmti-20210331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://rockwellmed.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>rmti-20210331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:f945e035-252a-4ea6-acd4-1e709520a8d5,g:3405d109-d668-4000-83c6-500821b09bc6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://rockwellmed.com/role/Cover" xlink:type="simple" xlink:href="rmti-20210331.xsd#Cover"/>
  <link:calculationLink xlink:role="http://rockwellmed.com/role/Cover" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>rmti-20210331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:f945e035-252a-4ea6-acd4-1e709520a8d5,g:3405d109-d668-4000-83c6-500821b09bc6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://rockwellmed.com/role/Cover" xlink:type="simple" xlink:href="rmti-20210331.xsd#Cover"/>
  <link:definitionLink xlink:role="http://rockwellmed.com/role/Cover" xlink:type="extended" id="i55a007868a3b402c8c5b3852b4629f69_Cover">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesLineItems_2036e1b7-3d60-465b-adc1-bc0fddbd4c8f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_41db4767-feb4-43e2-957a-3733218752ea" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_2036e1b7-3d60-465b-adc1-bc0fddbd4c8f" xlink:to="loc_dei_EntityAddressAddressLine1_41db4767-feb4-43e2-957a-3733218752ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_e7e311fb-3b39-477a-a90d-4b9628ebd63f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_2036e1b7-3d60-465b-adc1-bc0fddbd4c8f" xlink:to="loc_dei_EntityAddressCityOrTown_e7e311fb-3b39-477a-a90d-4b9628ebd63f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_5c5744be-e729-4126-9496-ee2db8579fe7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_2036e1b7-3d60-465b-adc1-bc0fddbd4c8f" xlink:to="loc_dei_EntityAddressStateOrProvince_5c5744be-e729-4126-9496-ee2db8579fe7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_417e83e4-5ce4-4388-90f8-6864f1e6c393" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityAddressesLineItems_2036e1b7-3d60-465b-adc1-bc0fddbd4c8f" xlink:to="loc_dei_EntityAddressPostalZipCode_417e83e4-5ce4-4388-90f8-6864f1e6c393" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesTable_8eb698a2-7bd3-4d02-9d68-651a7b0c3b3b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityAddressesLineItems_2036e1b7-3d60-465b-adc1-bc0fddbd4c8f" xlink:to="loc_dei_EntityAddressesTable_8eb698a2-7bd3-4d02-9d68-651a7b0c3b3b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_ffd406f3-6082-4688-89a5-1754f8374e0f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntityAddressesTable_8eb698a2-7bd3-4d02-9d68-651a7b0c3b3b" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_ffd406f3-6082-4688-89a5-1754f8374e0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_ffd406f3-6082-4688-89a5-1754f8374e0f_default" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_ffd406f3-6082-4688-89a5-1754f8374e0f" xlink:to="loc_dei_AddressTypeDomain_ffd406f3-6082-4688-89a5-1754f8374e0f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_59e31b89-84db-46a6-ab7e-7e12d41f4453" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_ffd406f3-6082-4688-89a5-1754f8374e0f" xlink:to="loc_dei_AddressTypeDomain_59e31b89-84db-46a6-ab7e-7e12d41f4453" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_FormerAddressMember_53312d8e-8d01-4285-b8a2-80a96e3f8c89" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_FormerAddressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AddressTypeDomain_59e31b89-84db-46a6-ab7e-7e12d41f4453" xlink:to="loc_dei_FormerAddressMember_53312d8e-8d01-4285-b8a2-80a96e3f8c89" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>rmti-20210331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:f945e035-252a-4ea6-acd4-1e709520a8d5,g:3405d109-d668-4000-83c6-500821b09bc6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_1c92f6a2-67be-4929-9c8e-c8b59180c3e7_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_6f0988fe-8acf-4e04-8310-514a6f468c4f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_99628f66-8e16-4965-bf61-4fae2b034522_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_8ae057cb-8e9e-4f8b-8e5f-fec3c0b86b33_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_f1f2a89d-054d-42bc-adee-f1859ae7679b_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_82ad3751-139b-41db-b29b-a90c7ebda35b_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_a281484b-d4ff-4126-a678-5406d02733c8_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_c572993b-dc38-4d8d-8542-fa30086c8f96_terseLabel_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_label_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="lab_dei_EntityAddressesAddressTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_d110dfbc-14ac-4e2b-bca3-1c5ae7e65561_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_00853371-73a9-4186-80eb-01e6fa59ff3d_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_16539970-f40f-4fbd-bdeb-4abe9ebd5aa8_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_6cc32d95-1b7f-4dfb-91d8-8fdbef476858_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressesLineItems_96a17d9e-5203-4ef9-947c-3b413e0a1bc1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses [Line Items]</link:label>
    <link:label id="lab_dei_EntityAddressesLineItems_label_en-US" xlink:label="lab_dei_EntityAddressesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesLineItems" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesLineItems" xlink:to="lab_dei_EntityAddressesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_abfd372b-4979-4eeb-a678-d72a770328ca_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_0f5e4718-f1e6-4afb-a374-335f57c7fbd6_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_2224fefa-44cb-4260-92f6-c5198e8554ef_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_30071267-8723-4b6d-9fd7-68df132da798_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_e430e241-b5be-423d-9d95-b0a341d3d891_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_0366e786-30f0-4da1-accb-7ec7b553b4d1_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_7d86f7a0-a0ae-4b9e-ab3a-d43294a6dcdd_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_705312f1-ff2e-417c-95cb-138a9c9c054e_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AddressTypeDomain_4fdf4caa-3912-4e08-890e-bf628b35c46f_terseLabel_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:label id="lab_dei_AddressTypeDomain_label_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AddressTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain" xlink:to="lab_dei_AddressTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_8b362c58-a0ec-442a-91fb-de11eb8ad0d0_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressesTable_5a26b13c-3bc9-40df-9218-cd34e9970264_terseLabel_en-US" xlink:label="lab_dei_EntityAddressesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses [Table]</link:label>
    <link:label id="lab_dei_EntityAddressesTable_label_en-US" xlink:label="lab_dei_EntityAddressesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesTable" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesTable" xlink:to="lab_dei_EntityAddressesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_41954038-907d-4553-8a11-5f83f1445a63_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_FormerAddressMember_e6d7b674-0316-4be8-8562-9f6be9fe6cf0_terseLabel_en-US" xlink:label="lab_dei_FormerAddressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Address</link:label>
    <link:label id="lab_dei_FormerAddressMember_label_en-US" xlink:label="lab_dei_FormerAddressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Address [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_FormerAddressMember" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_FormerAddressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_FormerAddressMember" xlink:to="lab_dei_FormerAddressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_5a7f3519-912d-4b15-8087-ceb374092418_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_ed146ce8-11cc-47d9-b608-7c4564fe6d27_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>rmti-20210331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:f945e035-252a-4ea6-acd4-1e709520a8d5,g:3405d109-d668-4000-83c6-500821b09bc6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://rockwellmed.com/role/Cover" xlink:type="simple" xlink:href="rmti-20210331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://rockwellmed.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_2d3f81dd-3988-47bd-885a-f8bfe14f40b6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_b7f64ed8-6d58-43f7-a926-a151c9e6d1cf" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2d3f81dd-3988-47bd-885a-f8bfe14f40b6" xlink:to="loc_dei_DocumentType_b7f64ed8-6d58-43f7-a926-a151c9e6d1cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_646e0869-2b7d-4753-a04a-52ce7d6317f2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2d3f81dd-3988-47bd-885a-f8bfe14f40b6" xlink:to="loc_dei_DocumentPeriodEndDate_646e0869-2b7d-4753-a04a-52ce7d6317f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_3488a0a3-2d4c-4a59-bd64-7c720d66ed01" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2d3f81dd-3988-47bd-885a-f8bfe14f40b6" xlink:to="loc_dei_EntityRegistrantName_3488a0a3-2d4c-4a59-bd64-7c720d66ed01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_94d97c72-f268-49b6-9ff4-1ddbed4c2a19" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2d3f81dd-3988-47bd-885a-f8bfe14f40b6" xlink:to="loc_dei_EntityIncorporationStateCountryCode_94d97c72-f268-49b6-9ff4-1ddbed4c2a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_8e0ef8a6-c09b-4fe1-815f-6e41c3fde1d0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2d3f81dd-3988-47bd-885a-f8bfe14f40b6" xlink:to="loc_dei_EntityFileNumber_8e0ef8a6-c09b-4fe1-815f-6e41c3fde1d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_4e4e2621-4725-4d39-9b5e-5193517b200a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2d3f81dd-3988-47bd-885a-f8bfe14f40b6" xlink:to="loc_dei_EntityTaxIdentificationNumber_4e4e2621-4725-4d39-9b5e-5193517b200a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesTable_8eb698a2-7bd3-4d02-9d68-651a7b0c3b3b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressesTable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2d3f81dd-3988-47bd-885a-f8bfe14f40b6" xlink:to="loc_dei_EntityAddressesTable_8eb698a2-7bd3-4d02-9d68-651a7b0c3b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_ffd406f3-6082-4688-89a5-1754f8374e0f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesTable_8eb698a2-7bd3-4d02-9d68-651a7b0c3b3b" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_ffd406f3-6082-4688-89a5-1754f8374e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_59e31b89-84db-46a6-ab7e-7e12d41f4453" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AddressTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_ffd406f3-6082-4688-89a5-1754f8374e0f" xlink:to="loc_dei_AddressTypeDomain_59e31b89-84db-46a6-ab7e-7e12d41f4453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_FormerAddressMember_53312d8e-8d01-4285-b8a2-80a96e3f8c89" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_FormerAddressMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AddressTypeDomain_59e31b89-84db-46a6-ab7e-7e12d41f4453" xlink:to="loc_dei_FormerAddressMember_53312d8e-8d01-4285-b8a2-80a96e3f8c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesLineItems_2036e1b7-3d60-465b-adc1-bc0fddbd4c8f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesTable_8eb698a2-7bd3-4d02-9d68-651a7b0c3b3b" xlink:to="loc_dei_EntityAddressesLineItems_2036e1b7-3d60-465b-adc1-bc0fddbd4c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_41db4767-feb4-43e2-957a-3733218752ea" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_2036e1b7-3d60-465b-adc1-bc0fddbd4c8f" xlink:to="loc_dei_EntityAddressAddressLine1_41db4767-feb4-43e2-957a-3733218752ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_e7e311fb-3b39-477a-a90d-4b9628ebd63f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_2036e1b7-3d60-465b-adc1-bc0fddbd4c8f" xlink:to="loc_dei_EntityAddressCityOrTown_e7e311fb-3b39-477a-a90d-4b9628ebd63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_5c5744be-e729-4126-9496-ee2db8579fe7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_2036e1b7-3d60-465b-adc1-bc0fddbd4c8f" xlink:to="loc_dei_EntityAddressStateOrProvince_5c5744be-e729-4126-9496-ee2db8579fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_417e83e4-5ce4-4388-90f8-6864f1e6c393" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesLineItems_2036e1b7-3d60-465b-adc1-bc0fddbd4c8f" xlink:to="loc_dei_EntityAddressPostalZipCode_417e83e4-5ce4-4388-90f8-6864f1e6c393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_4b66578e-de38-4806-9700-6e72a8ce82a0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2d3f81dd-3988-47bd-885a-f8bfe14f40b6" xlink:to="loc_dei_CityAreaCode_4b66578e-de38-4806-9700-6e72a8ce82a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_09480483-3210-42ac-9098-d52a913fe531" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2d3f81dd-3988-47bd-885a-f8bfe14f40b6" xlink:to="loc_dei_LocalPhoneNumber_09480483-3210-42ac-9098-d52a913fe531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_e34ac871-bca3-4881-a535-38661112d93a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2d3f81dd-3988-47bd-885a-f8bfe14f40b6" xlink:to="loc_dei_WrittenCommunications_e34ac871-bca3-4881-a535-38661112d93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_80f7938b-e394-4617-bac3-b0f4ee4e2d39" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2d3f81dd-3988-47bd-885a-f8bfe14f40b6" xlink:to="loc_dei_SolicitingMaterial_80f7938b-e394-4617-bac3-b0f4ee4e2d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_d7ff07ea-6f8b-4af1-ba64-9651a72692a3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2d3f81dd-3988-47bd-885a-f8bfe14f40b6" xlink:to="loc_dei_PreCommencementTenderOffer_d7ff07ea-6f8b-4af1-ba64-9651a72692a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_917d57d9-5fe7-4d14-9ee4-bd21c33bb007" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2d3f81dd-3988-47bd-885a-f8bfe14f40b6" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_917d57d9-5fe7-4d14-9ee4-bd21c33bb007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ba719af3-7073-4bbc-8277-d0c2b663c2f9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2d3f81dd-3988-47bd-885a-f8bfe14f40b6" xlink:to="loc_dei_Security12bTitle_ba719af3-7073-4bbc-8277-d0c2b663c2f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_57b694ce-01c0-40a7-8811-fca771e633cd" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2d3f81dd-3988-47bd-885a-f8bfe14f40b6" xlink:to="loc_dei_TradingSymbol_57b694ce-01c0-40a7-8811-fca771e633cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_4d4323eb-3a9c-46d2-a709-03e6b6c619e3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2d3f81dd-3988-47bd-885a-f8bfe14f40b6" xlink:to="loc_dei_SecurityExchangeName_4d4323eb-3a9c-46d2-a709-03e6b6c619e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_134225b4-447c-408c-87de-19f9538b0ad3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2d3f81dd-3988-47bd-885a-f8bfe14f40b6" xlink:to="loc_dei_EntityEmergingGrowthCompany_134225b4-447c-408c-87de-19f9538b0ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_593b4e0e-42f2-43da-ba9f-694b69707add" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2d3f81dd-3988-47bd-885a-f8bfe14f40b6" xlink:to="loc_dei_EntityCentralIndexKey_593b4e0e-42f2-43da-ba9f-694b69707add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_02763461-5ef9-44c2-a300-4f67c478a89f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2d3f81dd-3988-47bd-885a-f8bfe14f40b6" xlink:to="loc_dei_AmendmentFlag_02763461-5ef9-44c2-a300-4f67c478a89f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image1.jpg
<TEXT>
begin 644 image1.jpg
MB5!.1PT*&@H    -24A$4@   JD   %Y" 8   "\\+-U   @ $E$051X >R=
M3WO;QK7&05#^-+73.G^<B)3\"1K;FQL[7;1R:H'4HE&Z2^0N;RNGC210JQO+
MZR9*Y$TL@HF[:A.OVL;=-!9%?80VB;>VI/<^9_YA ((4)5$29;UY'H?@8# S
M>.<0^N',F9D _(\*4 $J0 6H !6@ E2 "HR8 L&(M8?-H0)4@ I0 2I !:@
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M/+C^[/AI"4.($2>1FI2574W MF>T/@7P0W,/E:4VFI'G$17O]+09UE=]T#;
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M42NG80:J+N7-U7&Q$B+0K'DQK>.+6)S6_6EC9VT8P2!6,]IYM'>TNO0$ZD7
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MMF^A+C&]I7%,+QJ -:$!TXM+:HO9ZO@X2J42QA<W<K/&I:\\3VB^C^QWMY)
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M,"7W9CRI24W@O* N,^0NVZ$6>BR5)[2$P%\;=3^0*M<K?>6>]':K>T*JVG1
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M*D %J  5H )4X$04(*2>B.RLE I0 2I !:@ %: "5*"? H34?NKP'!6@ E2
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M>WO-0*Q-.^#GPP_QTBOS^.1C>4'(M>DTVKQJL_:@7O@@!ZARKB>D_@N?F9>
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M&E@E^#Z-"O# T933^_IB2/6'^-.Z/,^HJR^M2_)I#ZZ9A*6@NJA]N9OC5RI
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M0YKVPGD>/1F2%P]?%"'QAM"[\AE/H]Z=P'IJ-83&XMFKQ%"?F1 #[[RJPZM
MVE]4I@D1<&4YHA,P2N_+)7LZ9"$S]5S:]HE3U=V7:T]1N>9:J:3 PYJ6871P
M]^%[3J5<_[MNJ%QK^\258T#>?5<WE[;!I3O@ST*B.V_O*:^AO<ZD)^)=-WE%
M,W6<;X-\SY=C12^\7Z\C>$@%J,!@"A1 *I(:PFJ,3;,*=D\@%7"M9//5;&C
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M0(,S]$^FYZSV'#D^4?TY<G\R\JM:C] CK2#U4?LI^(\:T 9H [0!V@!M@#9
M&Z -G+0-V#!Y0BH!G2\HM ': &V -D ;H W0!D;&!@BI-,:1,<:3?F-C_?0:
MT 9H [0!V@!M8'1L@)!*2"6DT@9H [0!V@!M@#9 &Q@Y&R"DTBA'SBCY%CLZ
M;['L"_8%;8 V0!N@#9R4#11 ZAJNR/)#%^>Q,#>%V8?].D?R3F%!@9X]EL]+
M>US7K\R#G5NX'N#*BG_M8\Q>U,NS9---GI4IO73+Q7FL[@FJ:[@R4#Z__I/1
MX:0,B?7Z?<]CVL/1V\#"#;.=9G )[W[U([[QGF.KMU]7RU.=_^!;?+.AVV+3
M B]_41K[;K"^6[W]AM'XGTYCJYV<"V49L"# FW=_T.<?WL$%M>S1:WCWRQ]4
M?]E\YS_H+L.6Q<]\?]S'M7+H[:@6X,V/O\?7QLY%K]7;XWK9J2# 3][_/:Z$
MW?D_G=-Y?O+^/S+74N^\WL7?/_M=Q>WD]>;__:=;P[]\B)^.E5$*7L-ODO^:
M\__";U\=0RA+Y_WL?_'GUGQ!GFQ]79"Z.G<)Y^<>X]'#>9S? S8%# ,#J?[Q
ML7>R <YN&'V,V>N7<+X ,%5["]*[VVY@=Z"\3[$Z-V^@/2MT=[D\3TUH [2!
M ]K RDU<7=%@JD#SXCP^W?@Q.RJR<A,7Y@RD/KR#JW./-2RMW$3I^AJ^^6J^
M.\W[0\^^&:!O[GD:VY<$@=$;:_A&]<=]7 UOXJ,GGYM/Z3.;9EXLBLJP9?$S
M:].BQ[W[6-Q(7\H6WWX'"T\T]&N;%8B]B8^^DS0-M+.M[]U+7";_O7?PTMP_
MNP&+NG?K[FLB /KVY_C;$WGFW,>UL9OXZ-^IQMDT[_R]#_';KWXP>DOZ.^8Z
M_SC[N^L-J?(VLJ<G50#.>E+]XVPEQ_&P$[@NA-2Y-71Y61_.8W9NOA!>B]LZ
MJ"?U9#4H;OOQ]P7;0<UI \=I VNX6IK"0E](?>Q&C!9NA+BR\@.^>5B0YO\A
MXG'_/]2B3P%@BG?4O1PHK]X;N'I]"J7KG^-KTT>+-T)<M1[6@C+X^QGT]W,?
MU]Y>P]<*ENPU J9O0(/I?5Q[Y0X^=>=S^0FI>]MXP7- O*@OS?W#0.I3R/=K
M=ZVW5'X7O\;8C<_QU^_TB_/B+\[AZMV_X]U7M!?UY^)Y79$\G^7R='MDNR#U
M45N&J0,$U]>Z&J^]I3H40 ^1^U!FC\VPOWAB+\YC5GE;O?*4A];;22GOH;3#
M\&K'(P/ O<IJ2YUI:09/B0  ( !)1$%46;T@]9&4Z=V/\G::,M5]%-4I.MCV
M7TR]L;X&[M[L/;AR)-S!Z" =7-3^O70H, P^N.Q#B)^T!=I :@-KN*H\=SE-
M?$^J/$_$@ZJ&H'^%CRS0%J7QV=/UMR_5.J=Q$6#>NXGPY7E\8L!(@/3"Q=>0
M#;UX U?E14$\UT5EL \&ZX-[[^#:BO7,>7US[QTS%/TK_$EY5,VY?'Y"ZF Z
MY^U1(/25/^#/1MO%MP5"4\ LAMA_X!,)2]H0KVD9H0K%^'MOT#5U%D"J[DP-
M8]9+*@^X*>>I="$!"A)M'@VI5Q24"M3Y\: >L*U,Z7 "=6V_V%4I3\ZG(*HA
M-"U+VF'AL\M;JF[P,6;G!+9M67)O)LV'5-<!-E]!G09$%^9,#&N!'JL/UYQG
M.=6OH"P)D1A8!^^'Y]K)M)Y_-*C1P1XZU.W4ZK9Z^TZW%U7Z,P^IIH]U>, ?
M,N$!16G\C0WPG"T$S,=X[Q4_!O(UO/F6A-'Y\<&$U&'85V;HWG^&/;R#]V[/
MXT(8XKP7<]J5GY!ZP.>>%UNJ'(I^W*GVK/;UM+;OJUC4\^\? %+](?X41F7H
M_Y*>:*0:9#VC F!92%UPX.H/D>?S&>^G]4#ZQB7'SLMH(;:X+!],I7T]/:E2
MIO6FKLSK25UY2.U;IX"Q#]W[T4,>=$7M3^%5)JGM/7EK@ =F7D=^/^ /D%H/
MXP\(RS@&.^H!HDK[GN<>X[V7;^; MBCM&-I_VI]1A9#JZ2;QJ2_/X].[4PAO
M^,/];V#V*Q-'N5<9IUVC(VM_;NC>U>,/\<L+PQN8_5+B)0OR$U(/_S=2XE-?
MG<<G&8]U?KB_@O>^],(!VD\A(0#EZZO><']W'GF.=7E2\V"J)E&I^-0>$+A?
M2/4\D$5_Q!0,6Z_E]?Z0JO*:87QUW#71RWI2Y:&A/;!7K"?4@]2]Z[20*67H
M-LDUA5#<I8>IVX&H ?8]="C2AFG>P]\]D)A&NSBC-B!#]3(!2H:,Q7-D)E(Y
M>^@%J6YBCZ=;41I_8WO_ >\'F#+L7[ID9O+[DZ7NX^HK\VF<9+\RV >]^R _
M=&^U>G@'+[F)4QZDKA2$!A!2>^MK]>SW*</^Y=>]V?OVF>)-EI*7@U?O=$'L
M3V__ 6_*I$(UX:H@CZFW %*G<.6Z]9I:+ZFN6 ]A:X^BP*L&0^U5=<?6TVH^
M\_F41]/+8R'8/EB[RY'V%-?IXF>]NFPY>H@_Z[%U8.F\IG:I+7N_)G^0UBGA
M!/:^,_=BXU4S=5OOZ*54PU[7>QK(,B5Y'=+[L)W.3VI"&Z -:!M(EXZRSZQ?
MX:.[4R@)%'WU(U;G]!)4\FP)WOH<G_K?+^JA_DP9)HWZ#OX;LTM0*8W5\]P
MZ8K :0G!Q3^XN%2EJX)669:J>PDJW4^?N8E5[(>]^R$S=*]B4%_WEO9*EZ *
MWOI,Q3UF\N>6J;)YJ/O>NFM;%C@-]3)2UH.:!U;U/53VKI:@<M\#!/]C/*@N
M+1LNX/=#%Z3Z)X_D>&7-6Z+)]W0.*$X_JC]-YZC#X=[@3E-?LZWLZ^.R@2*/
MZG'5?=;KL=IS&:^3^;U3_Y/1W?_=_^5#_/9>P40V/\\^CS.0"OY'!:@ %: "
M5( *4 $J0 5&2(%@A-K"IE !*D %J  5H )4@ I0 :4 (96&0 6H !6@ E2
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M[3T/!0P/79=JK]?^KMH2Q%&$2B5&3TS=LXRN0@^<T(GC?;T [#?_@1O&"ZD
M%1A]!9(:2J42IIL%<)G4U'J=TP92U<TD-51C#U([#51+I0)P'?U;'XD6MFH(
MPU(W7'8:F A%U[;^@RZ-;370Z'C]U&JAM9M^;]5J2+SO(W%_H]*(5AV3\68*
MJ9T&)LLA*EW@:AHL^1MM;"M(;:%>KJ&Y+2\*+=3':F@^B%!+=E3?; G45I>P
MH<Z/R@V/4#M:,YA)ME/(G%C$D^=-U,_5L?Y,7@Y:F'''IMT"L/4FGJNW"G/^
MR1(F,FEC"(-;^*)7&3D)'*1VX@J"?@"7NW"X7SN(*X?WI,H]]/2D)C'BCM33
MS_L)]"UC:#>]W_O=;_ZA-90%40$J,'(*)*C59*2KR).JSS6CDO.DJN9G(%5[
M4*M=GM61N]$1;5!+Z=^,C+?:>>*TQ[3J ZKG12WVENJR=NVBD"-ZQR?6K RD
M:@]J=2GO6?5:UP6I$UC:V,:.0.ID ^T,D!IP?:Y''+Q2>-BE@ '.!Q'*]74\
M,ZYM\;36U[6W5"X1C^EDO.$\H^K[1$6]5%AOJ?:J5HP7MH69RPVT^_2!@]2]
MAL*UMS-(0;83*Z]DK+R@ 0*/#KOR(D%4B>'RVI "YZDM@##CU=2[>D1(>M8G
MU]K=5WI[4I-8>U %0KN'_ O*,/4E N_2WBA1 *N.%<R+Y[E?N[SSZOH(B0U%
M</<FP.QI(^6Z<YYWV:69_$&$**.[]H+;/NC6O\OBF$ %J, I52 QGK>BX?[T
M7#K<KV[3AU3E18T039=4&$ PW4R]?J=4D^-LMO5\NI *"ZG*B^KKNHZ=W0XZ
M:NBNI8;X,QY6:72KAIJ$;-@RCO-&3D-=/J0J+VH-T\YNU[&='R;.0*KH6U<A
M T$PC0==(-1"O9Y@)U_&:=#EV-O8PLQ,@O;21!>$UIO/4T]W:P;G)I;PQ&BM
M(#:ZA;!:D!;*KE36H]K[AC*0:B%'LCO0$1!+(N>AU)"7.##4;&J 3%^X1U[;
M& %#Z]4L@%2;#04 *=!K %?:8]LM;?98V94 )(AM\*B!3W_(O[N,M$X-M!H"
M];%N=T6!<07ZT]:;MDOK%R&VWEU?PX[H)Y[CM)[N=NMZI-D=E]_VB[W6ZB<>
M8!,^X-=3".2>+#RD E3@="F0&*B19W0^)C5SK@^D2CA +4*S*60D\9$E1'YH
MP.E2Y'A;ZT%E5TRJA #4(JQ+",:NAM(H$VO:0FTBQJ8'119XR:@]NM&'5 %.
MI:_$[\I0?HAH?3O[@I6'U,XREALQJJ$)$?"TWUI>1FN'7M0>RF>2K5:;!9[2
M#*1B"\N7;<ROC67=0#R92_MB$7$CQD2YC,J@,:D*U#+#_1XD66^B]8 JHM(>
M0 U[DE</UZMR;#[C@90'H7A2'1@***H\%K+2ZS/*9/+Y9:3Y?3"5NKMA3Q&W
M]H:Z=MEZ=6W%9137!P66<KUM0[]\%B:EL_PZ[;52OW^]N?O,?4N:G]\[%@^K
MZ0L+X<7ZFW+Y006HP"E6P$YT2D>.9&1'3XCJ=TX1;1J3ZGM5Y>G2J&IOWBE6
MYGB:[DV <G]+ HS;X?U6#1/QIH.F3F-"Q3_Z7M)6HX&.2^!0_Y[]EH-4%6]J
MB%XF5M6;_2 U'>*7OZ'+DQ.(VR:_@UF^'NS=!S.XW&CK(7SQE&:&^R^CT383
MJO(%27SJ9(P-WX.MTB90J2R:=(':2<0;/<H X#RI"I8<5$IM D,:K(KASX>K
M%)SVRJL@R@!K$EEP2Z^W]]F=KW=]UI.JKLG H"[-#O7[9?M#_NHZ0[=I&<7U
MI;K8-O?+)Y[4U,-IVYF%3O]Z'1-K8X.+];'UIGT41>DD+&E_(:C;F^<G%: "
M+X0"79Y4[Z[<4+1-RX"I>$]K:"JODL!M%3%G]UNE!O[L\J1"O*=:5SVC7W3U
M/'4YB.50_P!2^Y J<:5N(I3$IVKHS&"F@T]!F&5,EFM85W&H'J2VZABK-35T
M;2UCN:4G4@W0FK.71:"TUM0QJ$JK)FIE;^)4KWA2N6ZLFIW];].^6,3$6,U,
MOMH7I(K^>EA;QX%Z\:?*&9F^O0O@Z>%LO:23!KLT+M6>4V_Y7EZ!-)?7O8GJ
M(7%5IT=7W?ET_5*W.V>\B&[9+/$JV&%]94X"=.EUVL+2- N#^?ON>W\N/C35
MP]ZGWRYW+&TR]YK>GFU#&BY@ =:_3O=#UAL;16F,K+J?),K=LPT)R-^WOGO^
MGPI0@1=# 0>I:J9_=ADI'U+M$E3J>6+C3\T* )*6607@Q9#F6.Y"06HTC5*I
M8I::TC&F,NM?Z2I#_:*S^1Y,2XQJBE0<ZN_?378)*FVW)O[4Q9C*LEW;V$DD
MYK2JEJ+:-$M6^?G]):B"Z0?86)HP,:KV[W=1K&K_=IV5L_ZR44K3X!8>R(Q\
M@<VRQ).:):C4=P.D"D1#!.,++BX5!6F9LF]]X29B%6GK>5*+3C.-"E !*D %
M1EZ!3@.-'FNFCGS;3WL#K?8I?Y[V.SI=[3?Z>^&FIZO]+T)KC] CK2#U4?LI
M^(\:T 9H [0!V@!M@#9 &Z -G+0-V$$'0BH!G2\HM ': &V -D ;H W0!D;&
M!@BI-,:1,<:3?F-C_?0:T 9H [0!V@!M8'1L@)!*2"6DT@9H [0!V@!M@#9
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M^:[[):UKN%\\J5>N6^^G]5SI1BHOI'G[T("@@4=[$OUCST.7&UZ7ZVPY<BR
MHX!1P$:!5Y:^^^8WP]R^)],!5-=;DI2K[\?6G_$J>-Y%_WR_^E?%^VKJ\<$V
M?[V^K]3;:L]WW;\?DQJ8\(/">^S1'YY^:7MLOZ3WKU=ND.^Z3;8]HD>F35Y?
M]^TG3SL7TYS3Q=4AL;,#ZF:OR;1I:'9RN!\>'US4CS9 &Z -T 9H _UM0"#U
MI9=?0\F.YOSL?_%G"Z-F]G^PGR6HSHS@9E*.#CGH+_)0-'DXCUEO<M50RCRS
MPPG'T%_4-C/#DO9*FZ,-T 9H [2!X[:!C"<5_(\*4 $J<$H4<&_FA:,FV1&9
MS*@)\V?G"0R@Q\[.SIY6$8;AOLMEOPQFIWOI3^T'T_$@]O;\^?.^MC\V-D:[
M'^ 9<A#M[37/GCU#T+<7>)(*4 $J0 6H !6@ E2 "IR  H34$Q"=55(!*D %
MJ  5H )4@ KT5X"0VE\?GJ4"5( *4 $J0 6H !4X 06&"JF=)$*EXL>(5! E
MG2._K4Y<05")<;":$D1>7$4E/E@I1WZ3K( *4(&SK4!20S7>Q&9<1<FL15A9
MVH2=8*#$Z3105;-I*UC:W,4N$M3"4F:]R.GF#G:-DDDM1*VYH\JL)9*?_Q4J
MT*IA(M[$SJ[HF5U_<WI])]L' %I&5]4WG08F5!^,8ZFMM>\T)A"J?M)IFXT)
MU)+N<@K;\J(GMNJ8C#>Q7BN;-3?'L;BQK6RSTYA$V:P_.[ZX@>T"@VW5RZ@U
MM[&S"\BQ7K=3ER%IV%K&I%I#5:=M-B91-_E?=&D'OK_6#"XWVMB()S%6EO5^
MQ['PY+G2U);1FCF'^OJS@C[8PO+E,93E&36^@"?/=R!YQT)A0UM.-L\7BQ.H
M-Y\7E(7AQ:0J4 P"5.+$P6*:=A3@UT$<)TJOPT&J%*%!E8!JS8^?5( *C)0"
M20VE*,&N0%(I0J+HQS^6U@I U=!4?XG-<;,)_934=Y/4:N9:R5Y3H&2AU0)K
MP=_]D9+BV!O3JB&L-;$CFK=::.VF,-\R>F8TD_QA"1I>6ZY/=F&.VS%J#?-R
MX96= =MCO\D1J;!51[G6Q':SAGJRHZ!(@6EU"1O;3=3+-32W!?1;WK'7=KE>
M:;^-G:2>EK$\B;(M8ZR&YG-3ACE.ZF.H-;,0YI5ZM@Y;,SA7:^)9NX&9QB:V
M%>W/X%Q]'<_L6X'D*8>X]:  4EO+6-[4?:>$:\U@)ME6 +JU?!EC$XMXLAYG
M\\B+70_H'9(GU7@CN[R9'<3*LUK!L!V4"DPC__%[&#LBI!Y&/5Y+!:C 42K@
MPZ@<5Q%;+VDUQJ9UI0IT*IC2;>F&S@2UFH"NG-?'S:BD/*D:LCIH5#V(/<I;
M.C5E^Y"9;W3+Z.DCJDYK1MI#O>OZ1.=1(!JWL6DNR8)I!XV)&I*=%(+S-;[8
MWWN IP/2)FKE"2PIKVH+]<D&VA::E# MU.L)M/;:DYKJU4)=@/1!I"#XN7J1
M$T^KA=,M+$_6#0"G5YV]HQ9FSM70?+:-W:TM;)D7LBQ MC SDV ]*A=X4E,/
MZ:TO"@ 64OX$JN,E-1J4S2/7UM%\KKWF5OOA0&H2Z:48"J QB=+A_TJEHO-9
MF)7P #/4+EY,ZWD-HMC ;03QRR:1N<YX:F'K\X;I@R!"+,/^DE:)$)EKM'<T
M090)0P@09-K:'U)=NU3]': 3>^49 "]*LRKSDPI0 2IP4 6<%]44(-_54/$T
MFA90 70:514.8)/D>V8(/ZFY[]:CF@?9KFL.VN87Y3K/T]EU2RVCI\>HUK-J
M==V,)U2?&":"#/.K87V!5S5L/8UU#TK=>:_,KGI?U 3K1;5BN?O4\+FC/'K:
M4QH$TUA7'E67":UZ'<G.#A)ON-\[JP"VO32!B;BMO8-JY#\=ZM]:3H_3Z\[8
MD?6B6O@W'M,@N(4' J[*XSF#9'L;2:'G<PM;6[O8W148'4-UX0GL"X%64@"W
M@;:$O13D$4]K?MC_6"$U$G=J)U9@&B4:#!4KNC3C>16(E;1*A$2=TR"H@5?
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M;,. U$Z,2J6".(E1"0)4#)EVXCPD'G-_=Q)$TJX,*)O[)J ><V>P.BI !:@
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M$._=GL>%,,1YQJ0>ZPNAC4W]R?M_/PRD/M5>-P=O&FC<1*&\QU&^.Z@5:+*
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M$G;176]><WX_]A^Q_X/F\1$ PO^W]S7M31SIVOHPOV8@,\ $L&SS"TYL-B=
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MGJVNZV%M567O'LD[MFWJ^[V$W=!(GA$!(D $B  1.#0$FK4QC$9KV+3,L[F
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M+WO;'EU>/F0"\P)3ISU[W%9,YS#UA$YS6$[#?NE[]($!]8'%ZS@U_2.>K;[
MIV?,)O*G/\>#U5^P=/L\\GG]?7KR,ZGSIJ7LP?1Y3"S^@F=\>=_?W[[[>IX$
M[X+YAQ9.?O8#-/ZOU=SP&<MXQN[?P'O3/^+KZ0LH%/+XU1__B:>K8;VEV\/J
MFFR?J*\OXU*Q$/R#"A]\^3,>3"?U[/G$XL\M[7$>0GSWC,?]3_#KVS_@^Y>_
M8.ZC$R@6Y#OH??PN_C>>KOX+?_CM$ KRO?2;/^._/[N B7M2GO390E+%@*7I
M<S@Y_6+'AW1I>@:S^_!%UMJN$-60E"Y-7R-)W0?L]^Q\M&''9X1X)E\TQ.(
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MB  14 B0I-(1B  1( )$@ @0 2) ! 8. 9+4@9L2&D0$B  1( )$@ @0 2)
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M=HVM"4EM8X^7GB#$5*4J".&U1D'?5XZ3^W4Z@XS'U#=U;)I#TF<V8"PE D2
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M=51<B/\5%L9&$:U)Z#^HS).^(/ *"Q>KJ&^84/ZK!5P<B[#J%.U;N%A;<ZD
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M>)Q)#L=&$D\?H _0!^@#](']]P&;IDV22I)*DDH?H _0!^@#] 'Z 'U@8'R
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MQYA;39Z%N:LW,/OR$2:*UW'W)_%S(;'Z>%81VW^3J/I8=G/\CR]PZ;Z#R-X
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MM2A[(O\7_OMOUU \^SF^4LKU&PAQG;@G(7_3_OU/<*E-JL7!D51%+K7**6D
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MZ0-$@ @0 2) !(@ $2 " X< 2>K 30D-(@)$@ @0 2) !(@ $2!)I0\0 2)
M!(@ $2 "1( (#!P")*D#-R4TB @0 2) !(@ $2 "1$"1U.=K;\#_B %]@#Y
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M*09/7W:&?X&X[HM???_3OW>-<!6+0_O2=Z<^<MSKO7W[%CGPCP@0 2) !(@
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M 9)4.N/ ..-AO[&Q?ZH&] 'Z 'V /D ?&!P?($DE225)I0_0!^@#] 'Z 'V
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M=C]H=PO+B<! (_#.K>XWQ#1037N;(7\!54\MO0N;R0LI'8FPEE9,>P N<U>
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M2G+>T8-X5(@+[23)I@_0!^@#] 'ZP-'W ;M!B0KW<T*/_H1R#CF'] 'Z 'V
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M&ULR'6WL4%-5581LTB.MGC7'X_#5 L:&BBC-OL2F(I@-W#I10?WMIO+=Y!C
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M!2-X+B3T(KFFTJXY7A<?T2$9FX>JSW5.JG^L7TRR[BLA6M?JNX1!Y9A_?49
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M;Q7<)*EIK^,Y$2 "1( ($ $B0 2(P*$C0))ZZ%-  X@ $=@K E12^Z\>I57
M3I4\F3NJ>?V?CT[Q)_;]QYY*:O\Q37^_='(N:BI)ZEY_'5F?"! !(D $B  1
M( )$8-\1($G==XC9 1$@ D2 "! !(D $B,!>$2!)W2MBK$\$B  1( )$@ @0
M 2*P[PB0I.X[Q.R "! !(D $B  1( )$8*\(D*3N%3'6)P)$@ @0 2) !(@
M$=AW!$A2]QUB=D $B  1( )$@ @0 2*P5P1(4O>*&.L3 2) !(@ $2 "1( (
9[#L"_Q^XI5N+06A"V@    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image2.jpg
<TEXT>
begin 644 image2.jpg
MB5!.1PT*&@H    -24A$4@   G    )]" 8   "UC4]]   @ $E$051X >Q]
M3U<<Q_5V3P_?)K(2Y%@V _H(1EH9:9,@'3,S6B1H&:-L$Z1C 0VKUX)U;&*T
M$O0X_':1M+,M;Q(!PU>():T%W/?<JKI5U=W5P[\9F(%'Y]C34UUUZ]93=^AG
MGEM5$Q'^ 0$@  2  !   D  " P4 M% >0MG@0 0  )   @  2  ! @$#D$
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M  $@  2 P(D1 ($[,71H" 2  !   D  " "!\T$ !.Y\<$>O0  (  $@  2
M ! X,0(@<">&#@V! !   D  "  !(' ^"(# G0_NZ!4(  $@  2  !   B=&
M  3NQ-"A(1   D  "  !(  $S@<!$+CSP1V] @$@  2  !   D#@Q B P)T8
M.C0$ D  "  !(  $@,#Y(  "=SZXHU<@  2  !   D  ")P8 1"X$T.'AD
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MQ !B #& &$ ,( 80 [V. 1 X*'*0S!$#B '$ &( ,8 8&+ 8R! XPC\@  2
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M#$@,@, -R$3AFU!_?Q/"_&!^$ .( <0 8N L8P $#@0.W[80 X@!Q !B #&
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M!V[?P8]2!:Y#FT#P,O$:7SZ]KY; *>)^F )W/!^//W^G'P_Z!(:( <3 H,4
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M3M)]QR5P/CG1=GUBXI$ECV!PO7#?[@^(I$^=KT)\7!U1S_+CY%V;3&SG)H0
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M F/&'U'$ &( ,8 8Z*L8**QKP_STU?P<A7]L/J:K'\]2* 5ZVK%D"!SA'Q
M D  "  !(  $@,# (! -C*=P% @  2  !(  $  "0$ A  *'0  "0  (  $@
M  2 P( A  (W8!,&=X$ $  "0  (  $@  *'&+B\"*0))>W+.WR,' @  2
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MZJ"01]\'_]I3X,K[<Z/25V%\PNWSF!D+N4TI=DXZ$3BC4ED%-..6\ZG<#_V
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M!LXR!D#@0.#P;0LQ@!A #" &$ .(@0&+ 1"X 9NPLV3WZ O?)A$#B '$ &(
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MUK[AFT_XFP]P 2Z( <3 18F!S4?T8/F=/>.M6\]0V#E#,KOYF![(CN$NQN7
M$3A1Y$2A0Q">81!V,? P;Y@WQ !B #%P2 SDU[KA;_#@?3'A5.K'L_2MOYFA
M2_.8(7"$?T  "  !(  $@  0  (#@T T,)["42  !(  $  "0  (  &%  @<
M @$(  $@  2  !   @.&  C<@$T8W 4"0  (  $@  2   @<8@ (  $@  2
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M"WV7X9$9BQNK7*6)3AT7"+I1":-ZG5)ANJ$R8ZC@C]]OJA7'C"UQ *]   @
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M#,@I,R!P(*\@[X@!Q !B #& &$ ,#$@,@, -R$3AFU!_?Q/"_&!^$ .( <0
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M #& &$ ,]#P&-A_1S=NS656NBP_^GOL/7]7.TEMW9NF[-_JLN%Y@GB%PA']
M  @  2  !(  $  " X- -#">PE$@  2  !   D  "  !A0 (' (!"  !(  $
M@  0  (#A@ (W(!-&-P% D  "  !(  $@  ('&( "  !(  $@  0  (#AH!'
MX-J4U.2L-/=:3P=L1!W<3>L19<<3'G,4U2AI=S 4O)52_43M@L90" 2  !
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M#P'>>3J6%,^#ZUX/L-1K!#@%>B,)GP?7I;X5@7NU_9[P'S! #" &$ .( <0
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MP,,',8 80 Q<[AC8?$0?79NE[TH.<LT\ Q$KERY6,@2.\ \(  $@  2  !
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M 0@  2  !(  $  " X8 "-R 31C<!0)   @  2  !(  "!QB  @  2  !(
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MS]3G;F,PR/8^?/A _$_]F+VZPO^  !   D  "  !(  $!@(!$+B!F"8X"02
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M:1\%QWJ255E+^SEL;/K+QU$(G!ZQ\]/R-($BK5-%?<G8T24<:_F)D+IX!0)
M  @ @0N+P#D1N#:Q>F.5#ON 99RS#W2M0K%B(G/@'F[2/OS0]^MY=JV"%+!G
M'M!%Y2OKDU*GK#]B1UX[C4T3.&[J"$@Y@7.JCM_98;[DQVW\$D6O,'[/E[I1
M_0)U[+S4M6(4JB)C4OB95*>ZYLI'Z)_KAN>R2. RV)3.FQN;]JE&1NPLQ%EV
M3EG5\E1..[6>$NG'[!'&IB'(I665^II5X'17;@X+!,ZF4NN4[KC8$1?Q"@2
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MPE0J>N;2K0;$[/GJ&"%M:J-MN4JE]OL\']LN&J/!=F.O.N?-Q@$4@ )0  I
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MM#D57@,X29_*M!A4)(UJH*5"5*FR@P!.(E[<MM*=B>A)!,[T78.A!,"9B)?
M%]]TT*', 629JPB<&XS/RYP"M/&,I0]YU67Q<=IV=[-#!(BB)%ZA !2  E
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MD(S+=_=)/T9$RIHF78O -55$.12  E  "D !*# F!?IKM%;RQO<QC8=A1J\
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M #XP3A](IE#':<!9&4NB92$="D<\*VL#.^"+\ 'X 'P /@ ?B'T@ CC"/R@
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M"00X(FJ,P.E9,F15 2Y5IML,><SC<]1-5^\7E O0Z?*1'X]H#B.W"QU" 2@
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M O$ QWO@IMJ4S=SV^^#"(T2RJ+QI1@K@FJJ\V>7](A]Z[]N;K01F!P6@ !2
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MYVW7=QSS-W>>BO:&'3ZEOWR]0.WVA^:1(M_QG:G1^=_2[_[P85BO7]B+"'4
M "  241!5/U7?-?JX0$.7R3C6&B, 3^##\ 'X /P@0-]H"D2AS^J)^>/ZE0D
M;@3KUY!"Q8?JP _5",3'&/ S^ !\ #X 'VCT@>U;],Y[N FA49])N YO?TGO
MOK]"W^KGP8W([@C@"/^@ !2  E  "D !*  %)D:!;&(LA:%0  I  2@ !:
M%( "1@$ '!P!"D !*  %H  4@ (3I@  ;L(6#.9" 2@ !:  %( "4   !Q^
M E  "D !*  %H,"$*1 !7)FKY\#EY01-I4]%1]GNGN&6F3F4E&<=*OHG.9UC
MCM$OJ&-LSBFHKN;4*>CXYJO^1)\LHY$L<YF3U;JJ,>NBYU0]C_=0  I  2@
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M;_M]7BL'G0/U<2H5'?M;>0XD!VG8T3!6%I5]A**5 SA7E_6)[1S>MJ $CJ
M%( "4  *O'D*^/1I;Y&FNSG]L+5'^_L]^F)ZBO(?0L3M^=U+-'WQ#CW9W6N$
MN.8('-GHF=T\SQ=K=R'V(*0@) EP++SNPX1_W&9]U3:J$\9A*/*\XM;0P(%$
ML'04RIQ70!&M>>@SMD>7IVS3MH>Z*;O(:"+ZI-O9.NY&BX;HF(<U(YT%-BD3
M6)2I!9 ,M@W6Q[;D.E5=S1D?(51KXZ&QLI^P6M?7DVB<W(IQ.-MD;GB% E
M"D"!A +]-9IMMZBEKX.-QS-T9Z?YXI_H'44GKH"D3_=Y(QQ=6MNQ^]TX>WKW
M$BUN[:J4*=_<L$A;N\U1N$,#G-\PKR_:%8#+?.0FP(R!"P<N9:X@H0'@3/T*
M:33"AQ&=84'W*RL1(*()X-*V!=LUH*7LTN>;QB 5'1/+JJ\":U)N(GL">ZRW
MU]6FEZT\87Z#];&]INJDYV_K&QO47;S)NLH7^'R(ZAW.-IDW7J$ %( "4  *
MO'$*2/K4W)? =Z9V:>LU0S;#VB4JGNZZ.U,-T=&EQ2W:'; )+@(X>[&.'\?!
M%V-ST781KSZG AWQ![X*>Z;T'CC?7UZ&/OQ?"S9B)76JXT01*[\72^^+D_U9
MO,0,"F)W#'':]J:Q?!UE6^[V_@UCEV^?EW[?7JV= 3"Q4=M>L5^ S7ANGXH\
MW(4J]K/&W+_])W.W\T[7J8SAUM)UT+@V]GP<??-S55J5/B(7WXWJZSI':;9-
M+,$K%( "4  *0($W4P&?/I7I<1K5['?+B!\KLN,?(9)1-G-[8/J4NX@ 3OK$
MZPDH4);J41]]*@I),Y[ 6"/LLE_DE;UO(^P<74$!*  %H  4@ )'4L  W*.=
M5X3_H %\ #X 'X /P ?@ _"!L^T#^^[1<  XP"O@'3X 'X /P ?@ _"!"?$!
M -R$+!3^$CK;?PEA?; ^\ 'X 'P /C!.'P#  >#PUQ9\ #X 'X /P ?@ Q/F
M P"X"5NP<=(]QL)?D_ !^ !\ #X 'SB;/C  X![3TGGWN(OS*[2QO4)+ZV=S
M$M:YE+W^T18996S[B4/:)LUE%VAI^RSK ]OP)00?@ _ !R;9!S9N_H;:K1:=
M^^-/]/"IK.5CNO%^VS[4]_R?Z=LG+VGU:IM:+;Y^?T"__^L+>GCBUT"Q!:]'
M\Z]_THU?3U&;U^Q7_T7_\\L+>K23*HOU;0 X"T/GEA_;D.KV"IW+,IH[ L!M
M+*_0ZMB<A^W6(,5@-2Z(L\*.=[[Q8A[-<= '=(,/P ?@ Q/C _>NT3O+/P>
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MS.TYFECKQXUM^E'C\1>8K^ML,E]J3?,TD,ASM[K(?!\UUJ\O!+XTH0E\ #X
M'X /'.@#%8#;,%MW&-3:E=0J:WF?+E_=I(=/7U:NY]#Y0)W'!HC_I(UM7I_[
M=&5JBM[YPS_H[T\>T\;_>TF/GMZG*]-25E_#), 9>*D!W"LR0.+*&;(DJN6/
MUQ=\&8NSL;T9(G ,-[Y/!BU.R=I7!C>;KK60:(\=C"V'/GF<<\O<IP5!&3\L
MQ " .Q_;>VYYQ:97%8@*Z!E K=GZRH"E&;,R3PM["[2DY\OS%XTJ]8.]^!!!
M"_@ ?  ^ !\XA ]$ *?;W:?+[Z_0=T_"A7[CYBU:?8KHV^3XUWVZ\NM;]*W9
M R=KFRJSYY( 9P FBFRYCCBBE  X&_EBJ-+[S[@- Y5-H7HX<E1K88SWV-EH
MFKW1(-27:-K<O(O,<23,1\-T&YFDC%>UP4'A^40_+@+G;W)87_"1.K__SX%8
M@,I!\]3VBSVI^MIF'$_.APMKA;6"#\ '3MD'&@'N%=V^>8LV)-IV[QJ]N_RS
M2\F=LLUCBV9-_CQO_^E+VGC"-S&$N:3*^'P:X-R^,0TQ#'7GYOD_FUIE ,LR
M"V=^XWX49>/!%="8]&+8#\= 9R-H&L94?9<.98"K1]ITFS!)@;YP-ZA+^[H4
M;:V?"L!YFQIL/7B>VGZ.P+D;.&JZ:)MQK!T5Q_ '^ !\ #XPP >: $Z7W[M&
M[:O?TX\,<]NWZ(:[J0&Z#M!5 =.IZ73O,_K/FS_1WU44]5&JS-G: ' \20<_
MU<B7O%>IQPV&.U<>0Q(#38A V52CC:0)'$H9O[=0:/?!R3X[3KM*'4FU^O<^
MS<GVREBV?Q.M\Q$[NVB^G:1L98^:S$GU5ZO+D;B&>0:[5Z+Y-M4_-><X"PX*
M&Z*_K. +9_P+%?X*?SU#/B"/$3'7MX__EW[\YAJUVRV;G>+W3U]25,=<VS[%
M30QG: UKW_GW/J.I=MNMX8:%-RZ;JI0EYC  X-Z"+]9*!*XF;$(PU'D+_ +K
MCHLV?  ^ !^ #YQQ'WB+ 2Y$["0:"#@#G,$'X /P ?@ ?  ^, D^$ $<X1\4
M@ )0  I  2@ !:# Q"B038RE,!0*0 $H  6@ !2  E# * " @R-  2@ !:
M%( "4&#"% # 3=B"P5PH  6@ !2  E  "@#@X -0  I  2@ !:  %)@P!9(
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M< =Z+K;#HVFBC,$A%( "4&#2%6@"N/X:S79+W,0P">NK 8X!;;I+#\Q-#!6
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M/7$SM_T^N$$32@#<H.HX=](*] O>HW?2HTQ6_]!DLM8+UD(!*  %H,#)*V
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M@ )0  I  2@ @(,/0 $H  6@ !2  E!@PA0 P$W8@L%<*  %H  4@ )0  H
MX. #4  *0 $H  6@ !28, 4 <!.V8# 7"D !*  %H  4@ ( ./@ %( "4  *
M0 $H  4F3 $ W(0M&,R% E  "D !*  %H( !N$<[KPC_00/X 'P /@ ?@ _
M!^ #9]L']O<MO +@ *^ =_@ ?  ^ !^ #\ ')L0' ' 3LE#X2^AL_R6$]<'Z
MP ?@ _ !^, X?0  !X##7UOP ?@ ?  ^ !^ #TR8#P#@)FS!QDGW& M_3<('
MX /P ?@ ?.!L^D "X![3TOF,LLS^-[<^#L,'C;E)<]D%6MI.V+&^0-G\9N*O
M!MV&CQ=H=4>7)?HZ-,@-LGD4_8<^-I8O^/60=9'7<\N/$_,/;?'!@Q;P ?@
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M4Y;*'A5%2VL3[(SGV:2K!C9NJ]^K<8TFAYUSL.4@6W$>6L$'X /P@4/Z0!/
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M4  *0 $H  6@P,0HD$V,I3 4"D !*  %H  4@ )0P"@ @(,C0 $H  6@ !2
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MFT@,P#W:>47X#QK !^ #\ 'X 'P /@ ?.-L^('P/@ .\ M[A _ !^ !\ #X
M'Y@0'P# 3<A"X2^AL_V7$-8'ZP,?@ _ !^ #X_0! !P #G]MP0?@ _ !^ !\
M #XP83X @)NP!1LGW6,L_#4)'X /P ?@ _"!L^D# #@ '/[J@@_ !^ #\ 'X
M 'Q@PGP  #=A"X:_A,[F7T)8%ZP+?  ^ !^ #XS3!P!P #C\U04?@ _ !^ #
M\ 'XP(3Y  !NPA9LG'2/L?#7)'P /@ ?@ _ !\ZF#P#@ '#XJPL^ !^ #\ '
MX /P@0GS 0#<A"T8_A(ZFW\)85VP+O !^ !\ #XP3A\ P '@\%<7?  ^ !^
M#\ 'X ,3Y@, N E;L''2/<;"7Y/P ?@ ?  ^ !\XFSX @ / X:\N^ !\ #X
M'X /P <FS <B@"/\@P)0  I  2@ !:  %)@8!;*)L12&0@$H  6@ !2  E
M"A@% '!P!"@ !:  %( "4  *3)@" +@)6S"8"P6@ !2  E  "D ! !Q\  I
M 2@ !:  %( "$Z; 6 &N7^34R3+*L@[E99_*/*?RB(+UBPYEW%>GH'ZECT'G
M*E7)U\VT+27EQDY=5FTY[/N2\D[%SG[A=& MY+\.%=6)##&$L3^AP1!-404*
M0 $H  6@ !284 7&!W &6O( *7T&&P&D/A7%85&N3T45C/PB##KG*_F#,F>(
M$EMLL06[N,PW.-2!P& %T!S$=1RU,=P>'^".HN.A)H/*4  *0 $H  6@P!E0
M8,P EYG(6W7>!I;R-Q7@>+9]*O(BCC8J@"N+>A2QJM$P[X^FXS ]HPX4@ )0
M  I  2APEA08'\ QQ'#$S*4,.WE)?4X9EKDORQS$V>B7K2L1JC)W*=.L0S98
MIZ-L)>7<7YD3]VN R43G<BI<.^DGW;=$X,3&#N6FG8K <=]B>]$/J=>\<//*
MJ>P7-EUJZDG$C>$M$5W3:=1*"E3FRG,IN7])%_/<1*].0:64<_10RGELTTZT
MYCFX**"S5;0X2XX(6Z  %( "4  *0('A%1@CP%FC^F45<@0N7 3.@(B#'P<Y
M><Z0QV4.L#2D93GEG *-($C@S@*829'R^53?AHDLP%E04FU\6M7::(>U^]=X
M#Y]/X;*=G [F_HT=O+]/ *YA,9HB<,I&"YMLCYXW,UR8;TC_5G1D:&.(-483
ME27W8OL!P#6L"8JA !2  E  "DR( F,'.*^+P%D9@T> %J[ISIF(E@4KWUZ@
MQH"30)6<57!E@GP6>&S$2OJQ?3/," 09$'30%MEAH$HB6O:U4Y06X!P@^9$-
MH'8H+QB8!OQ3 *=KB2TFCF@B;$<%.')10HY8EE0.-$9;@&,H  6@ !2  E#@
MK"LP/H!SZ4W/$7P3@XFJQ0!G4X2I"%Q&-G+4I]+D7F-(\^T,J<3G?,1*1;?(
M Z2+:&6Y2U7:L2. 2\*6&T,!'+>1Z!9'X.0XZ035/OLE%:6D9BUD!AOT6(FY
M&>BLZ&@&=64^.FG?#[0K:2P*H0 4@ )0  I @;.DP%@!CM..%DHXBF4?)<+[
MU?R>+W<;IKSG_7)V3QM#ECPVA/>:271)HF$218NC9*9]1_;.60#T_;B^@ST<
MI>NX/6RR!TZ@D<<+>^"R3MA;9U.[=DG-G:2EC0::.IY6*TONX$WV \JK94&7
M^F1]C.T:YMC&G#IJ+Z&TU39I0./Y!<8$P%56 F^A !2  E  "DRD N,#N(F4
MYW2-#A&XP]O!44<&N7Y1N?OU\%VA!12  E  "D !*'#&% # G;$%\>:H?7<Z
MHN;/'W!@X4]'WPYH@--0  I  2@ !:# Q"A@ .[1SBO"?]  /@ ?@ _ !^ #
M\ 'XP-GV@?U]RY@ ., KX!T^ !^ #\ 'X /P@0GQ 0#<A"P4_A(ZVW\)87VP
M/O !^ !\ #XP3A\ P)T4P*VOT-(VG'F<SHRQX&_P ?@ ?  ^\+;X0 +@'M/2
M^?IC..;6AW>*U7G7_OP*;8P0D+C?NAV;-,</^#V_0JO+"P&:ME?HW(C'']8I
M_/PS92_;8QY$?"'8J+5)G1^R;&/Y@OD9LG/+C\] Z)O78X%6]=R.<1RT3.B6
MTH?'2I6GRL2NU+E465/?TD_UE?LX)1\<UE=-O6/;N4ESK0NT]+>7A_:_U?D6
MS:T?OMVAYB?KLKU"[[RW0M\]'?Z[[$CCR'@[FW2Y]>&1=#G,N*M7K88/_;C'
MF]_JU3;-K;^@4?5WF+F@[O'6#OJ]7?HE ,X*P% 08(DORHD+:.H+8WV!3@0D
MUA<,I 2;@IUF/'/!%1L=A)[&Q9/MG-^D1RX"MSK/-FFHT<?B;+I,CN65Z\BQ
MO.HRU\=)Z9Y:XP%E%KA&!'#K"]X'#:1&Z]FD1:H\5798[:N:ZSZE+_UZBCXX
M8'WT%_S&\@JM[K"=+?,'T"C_V-+C-!ZO+U"KE='<-^, N,>T]![/\\]C!#CM
M#R=TO'Z-6JV6T7 DP.7Z^^@; %RCWP[Y^4+[$_)YZ.__4!X2X%X17T"' ;,8
M_$:[@*F^M5T;.@+'T!-=\$=K2^.'4Z(9.H4J4.<<KQ9)3)V?=R"HVZ3*)#)Z
M1@#ND0&"$0%<]$&M %-*,]8B57Z ;@:XA]$YU;?H']DJOG9*/IBT16R25P8W
M6:?3LW-C^</Q1> X(O;>"FV,+0(G6I_LZ\;-#^GR^LN11<Q&W5_C=^50?GJR
MVL$VZ#O)/C DP/'%D].!]HM^B5.DYU?(O+KT)?_USC#E?Q& HU [K\BGP#Q,
MZ3XNF!134W]66!?),.E'E9+T'WYKF[X(VW9J'&[K[#$7>-=7YE-]JJZSLV:W
MB?!Q/PNT.O"B'5)X$BW4D,FV54$T=?[<^1B839U$F8S!\TH"M@/*ZEH-JT.T
MAD9#I3<#34U+ 8-Z/6]KTB\.^B+9I#E90Z>AGJ]H.JR68LMAZJ?J2C\^;1OY
MA_*K<?A@=3V><FK3^;X[Y].5OJZ+$.O/\_RFAP%.<?HUGO_>E:MYF<\+C[-
M2_KSS_/5?9[7J4L7#7.^,S "Y]*>2V('V^  C%.'+?$_56X^_]RNU3*?UZ]\
MBM8"7*TO$W62;2,+]-53C@B&NBT3M7M)?CSW_M'VK<08VH\YA;I JW\36SXE
M;XMO*V5<E^W]GAZ:R&0<53-C\UK*V#N/Z<9[8?ZL82T"YZ)I=OT^M?/B<=_C
M[^Z6B7YF'XN><7^(P.EUQ+&]ID*'LZ;#0(#S7]Q91N>6-_W>.'/1JJ2WY&(J
M%U(ST5H=W4< LX/Z$_BJ1:X\Q DH2D2!'4V@4X[U.2[C\?GB5;&#^ZS9_3A
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M&.#J=?27?S@VH)-(31JP4U&<ZL5+0YL^CB\RX0)C^O-I4KD0!CNJ<Y /I8\
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MS('<L%H.6^^@=1U5/P>-@_/#?;'R'C1._[IT[9GS3ZSC<.L(G: 3?&!L/@"
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M%7P /@ ?@ ^<@@^\L0#G(U$F8H1TV- P@KU?^"(ZA2^BH?T3ML$_X0/P ?B
M\8$(X C_H  4@ )0  I  2@ !29&@6QB+(6A4  *0 $H  6@ !2  D8! !P<
M 0I  2@ !:  %( "$Z8  &["%@SF0@$H  6@ !2  E    <?@ )0  I  2@
M!:# A"D @)NP!8.Y4  *0 $H  6@ !0 P,$'H  4@ )0  I  2@P80H X"9L
MP6 N%( "4  *0 $H  4 </ !*  %H  4@ )0  I,F ( N E;,)@+!:  %( "
M4  *0 $ ''P "D !*  %H  4@ (3I@  ;L(6#.9" 2@ !:  %( "4   !Q^
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MHH_3UO--&S^YQ^T0DSQN>Q[*]Z'"=H<PX4Q5Y93G*%*7H^KG3(D#8Z# FZ$
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MT!X?3[=L!.MXQ VME./"(4RAGA- .BL-E5(FKGM.S!(S! %!X#-3."4  "
M241!5((CH C<RYUW(/^"@?B ^(#X@/B ^(#X@/C ^?8!>@RE$#@AKT+>Q0?$
M!\0'Q ?$!\0'AL0'A, -R4#)+Z'S_4M(QD?&1WQ ?$!\0'S@-'U ")P0./FU
M)3X@/B ^(#X@/B ^,&0^( 1NR ;L--F]Z))?D^(#X@/B ^(#X@/GTP>$P F!
MDU]=X@/B ^(#X@/B ^(#0^8#/0G<TG0%+BULE0XL7I]L%MFI7[X.DY51F-\,
MZY65A_7Z/4=Y,[!D!V$+YB^[YUVI9XU5XO;J7QA%>_Q^A'84ZW?_I<+LN;P(
MK<U%F(]@UUW&(#I#/$+[Y;P[UH*/X",^(#X@/B ^<#Y]H >!6X?YZ1FXA&3#
MDB+6D>:,>J!O@<"5E1L9K85%1K*8O)B. <J0;%4\ J=EMQ9&&<D<@ #UZ,=@
M3JW)FR7#FXMPJ2N9[(U++QS+\!C,[MYVB#S!2'Q ?$!\H-P'6O>_@*2*#Y_^
M#/[[YS?P8N<)3"6)]_#MZX_?P(\+NMZE;WZ!%]LQ>5MP[ZII=_DO\,.KMT"R
MO3:;#^!C?)BOU1>3)66#^&SK_A@D!M/_:O\;7NR\@^6O1B!1#QK_#*A,R_P-
M[GU:@Z0:EC^!&[6:/^[?MV R"<K^IP638;W_^1<\#WRB.X%K+L+\)A*/6/1,
M#[Y/CIQ#E)6_W$%Y/$KFV@P"9KQN7'9H"YY;(M6#((9MXWK[Z .2P9 (;R["
M9)?H9G==\;[Z;?JITX?M/3#R=8H\P4-\0'Q ?,#ZP.8#F+K_JR9D:[.0W/P)
MGC]>A^7MMXH$8+WEF[.P1.=KL_#1@JD??O>N/8![FZZ=U>&U07(X"]^]PGK\
M6,;$XA7BVNM\\R'<N/^K)E!KMZ!V\R?XQ^-9N-%\H\J0W-6N_ 7^^OL;>+GY
M$#ZN)7#IC_^$Y]MO_>SEVA-_W+^Z!4N/?W)CKTAA2=DK)/[^&'8E<$L+.O)6
M)#Q(#%QJTD7@RLI9*L]$M2HJI<K*=]Z!CA@9N=/KNN,8J;J\"/,JNE:!"I5;
M.3SJ%B<L/@E#G168G-;10YU6)4))]I3UPP?OY8ZI7V8C QMML+:S<N50L;Z$
M,BWY,SIM&T.N[7EO/ [MQ*'=<N[?G(*'X"$^(#X0^L#FELU@+=],8.KQFR"Z
M]@2F;J[#"YKL/3+&YQP7?;O^?2"#MR&2:.3%=7*Y<MQS3N1C^-4(3#T.HV$8
M69N%[W[_!>8_K<%'WT3(6^@7.T_@QE?K\/P5)WG]ENDQZT+@UF&>HD.&3% :
ME9,1OD:LK)RG\EJ;ZS8"Q\M?(@$A<J:B=+A6S1$I31*)8'&'PSH4(2PG<+3^
M#3_]Z)MK3_;,,[+%^Q<.LJX_"I<,F2VWT9!3VS]N/S\F6["?FL@2.49=:+>U
MD>'HVT4R4&X<#[\^UR_'@HWX@/B ^,"Q^P"2*I5"_=I$QAC&:[,PU7SK2!TG
M8]ZDOP4MM8Y<IU^]E"EK@RG5CQ9^L>DV/)]J!H3/D\MLD?+R'R 8>5,IU*_A
MV]_#:)@A7G]_ !_79N'ZEXE^9_27+?B'1] 8UFNW; 3/^EN_96:<R@F<%]%!
M,D$D29,1(A8\NL7)#B_WB00G%>Z8" IU!-MKHK4.DS;ZY.JK>D@L%=$AVX+K
MII.^+0S DO:3;&.&UY9AHFTC?5ULI!L"V]I^,!OH>FA+0)J1X/HZ23>3%<H0
M E=^,Q+N\BD8B0^(#YR2#ZCU:E?TVC6:Z[ST*=K!R!C5*7X^@:FKB_ CD0/6
M1@@<FQ-/8%R]=*F1W[K_$):VW\ +E5Z=@6]5E%6O=YO\/HS6:?N6,7T:I$7[
M+2-_*"5PE#ZEBHY0O0,\IFB9.C;DKJR\'P*G(G!L X(C@W%RI'090K0T/3B!
MZ]:>1^!X_P@+]TDD*FZCJX<#IJ-JFH09!S.D+&I+0. <'J23/K6LJ PA<#(Q
MG< 7F._7QI=%C_B:^$ ?/H!IT%E84NO3\-X)TJ>((2-CW>ZUY?L/H!5+NQ92
MJ%_ _-_#B)'<M]VP[7X--RC<@B6*PJW=@H]5Q/,MO,3C^QC]U&E1)'M3C_]M
MHZ%.;K^ITE@]-W81 H?$0*?O'-EP93J*Y%)\?DHR7JY)$*U?(UFC,#D]JG:Q
M$AE$DD*I3M)-97C.Y=ACDVK$W:>*>.&Y3562+B/7EAL2:MOB==Y^QJ8P_?XY
MX' @0AM"&]U@43L?'[(SE*-VTMIHFF^[K3N]:,9)DU=;;OO$^V/6$\H7;!]?
ML#16\EGT7\%$,!$?.)(/;#Z CX+U;E[ZM%\"%Y(\[YQO7 @B=3('''T.P$T*
MN!$%HY^TH0&/-Q_"O>9/>@.)(G=(]+Z ^9_UCE7/;_I-E<;JL3&,$#BY03V@
M&5BG6AY$X$Y5]UGU6?0>_<M%,!0,Q0?.E0^HM*E:_U:!BGGT!WV?A^E3K^Z7
M?X/GCV<A24;UHT>:>(R/!JE !:_9* \]HH258Q1.'B-R;'[@'B%2@<HG?U:[
M354JE<9#!4[,VCBU5BY1XW0=TZ=-7#OWN?>8D7Y3I;%ZY#OX*03N7'[9N<@A
M12+YH,FQ_,@0'Q ?$!_X0'Q@\P'<XYL<SN6<]8&,Q6&Q5]&YX]]((@3NL ,B
M[8[MUXU,1/+E)SX@/B ^$/$!3+E>89L59-X9OGD'4ZY7%^$'?$;<,8^?1^!
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M@1/R>J0;^:2_[$6^$ KQ ?$!\0'Q ?$!YP,4H!4")P1.")SX@/B ^(#X@/B
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M! %!0! 0! 0!04 0.%T$A,"=+MZB31 0! 0!04 0$ 0$@2,C( 3NR!"* $%
M$! $! %!0! 0!$X7 2%PIXNW:!,$! %!0! 0! 0!0>#(" B!.S*$(D 0$ 0$
A 4% $! $!('31>#_ ;4S@*?@+WCT     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image_01.jpg
<TEXT>
begin 644 image_01.jpg
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MP6BCY#]*B:(C,6YDZQ&.WUF6O!G!.P\X03E!A!5LA-2Q6^F\#%;N'QU*]+J
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M:/CB\,N3E+@@&2*LWQCAW'1YV3Q(=6F9V>DM.ZI>?V7/COH*C=KQ6R E!9D
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M,=4]@B=FM::8(#HQ^$5B?:+($;[?$&7ZE>MT]H[@'5E<7%H'0Z=_1'F [N2
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M3QQNL4*B)J'R1VN1C6&(^S_^[!/B"&:F*4*ZK%7(5$>4EZF!1A+7<O.R*(A
MC98]+;4[FZIVU%7 SBFB)24OM5@5*P@A)NF5.T,R<*IC1R+LXF%['W4-)B8E
M\MF(H=(68>CH26^?.8!1Z]43LH>MOHBQ/%TWWJY^=O71__/W?T2VX,C(#(S'
MYW^88I="Q.U;I_>2F_GEMPX#3!)QR"K_\0<W;]SNM"3<@ #+=$)-0E8",L?"
M[6FM_85WCA [@+*%#*$5/&-V:K=\1L;7UHAU_C_^].,/S]TA_F)L?";N%5F3
MNI!96:^?WOMO?^<;;Y[>D\>,M%*1 -ZK1832_?O?^^$'Y^X,04[GELRD[''>
MIFU(JWB2LE9567QHWPXR8;_SC9.P>;>"ND+<EKCP[OXQQO/[?_C!Y9OM&,XE
MJML8C\/Y5%@"Z/KNF?U?>^<(.2ZQ#;:6 J!NW.LB+_)/OG\>QI.(1LI^R9/]
MTFL'#NQI*"LK F\I2J$;UG9&A-R%_AGOAK/).<W'@&B0A.U3TS83+-JWD\J"
MA6*TC7 =6,[W?WJ%C+&+UQY+QFO<\@[+J:XL?O>U __ZGWR%Z/;U8W[F;S"/
M7[O3 87YLQ]<3,B9#0@[-MC_X7>^QHH@7<%XGOE9+_#"9]%UHH_?@.JFIHXO
M+!-R=JEOAEQ.ZDFCFARLRO_&[E+Z"Q1(-JC=P*0J>9%50W39#8KE7!]Z,#0[
MGI5>5I+]>F,1P6GE!9D<13GIU-)%O$CP?CB]. 8/QPDT/BT-E:@B+Y-D3[L<
M=C*WM#8^OT*,''XCOD$E8GB2D1,:]U,E-VAQ]6[_S-_<&+K:-3D\O5B8FWFJ
MI:0)-4J;+(0/7*_W10;C=1V"D1)U'<XBOZ&VNN3 [OK73^\_=K 9HM;<6,&&
MP2K2W"#:@[SAK]A)_-$D I?^*@<V(B1*PO"U[@MQ:U)?V0'7LU!V,[P(!>+@
M7J%36,G59)%"3H_EA8"RC]H'O2!L]A4CX&9+2Z40)N74&!BE-<C7.W%XY[&#
M.Q#ZH"GH#8C>C74J,-:4D<./*(?47%E>4%Z67UR<CT2/Q@.Y1/3VUJ6H+U86
MU&Q):#RH+XCGK<V2A0Y!]]5"Y5=29W#_D$B$)@%[6(7C*&%66N8HGHT6*H-E
M9F=S-;H=A0!.'6X!MH?W[4#+:6JHK*LI9?]75U"3M)BT$CX"$\H(H3527Y+T
M?K@R-()A,&"&))F>J:GH-)AZ4 C>>^O0Z>.[J DF&H:C]DY!,+#WJJX#8*4B
MCC;:<#@NXTW#5P$919 O+RLB"^?\M8>H$83A$4 H?:5T,GH;[Z#7/<)($)89
MP*Z=-:09HN6P"C654@# BK*LEWO<UDJ3'"P"SZ#UI'EB:XV?*B0?M"&_AV1,
MJO6(<\YJGJJBB5Z"<G/_42_ZY;VV7DVJ,5NZO8SE**8$?U3'8J&9Z<&]]0!6
M?/C.D"7_DJJ%$_':K0[8(;G,IIR'*">,(95*;E368.U ;^:8,#W408+]GJSK
MH.7 L9 /0-'6EAHT'KYQ6TG>V"9RW^B.J]3=%YQCNR\\3=2FQBK.J2,;JH!\
MU6!2#A:6KX/40A$'A+D83GP.NHY[*K&^DJ\S 32BV4M??%WGV;F.-Y^J<!"(
MA6J4Z)U<I-X:Q0C@): :$64GZO*QK366L)O50!7*\G+!S!+M=I:Z1^?N]TU/
MKJX5E>>V5N=CCJLOSM;]X\JU!%>I_5E%%[]+%7-- PBPU)$CQB:FB9P,#JQJ
M<)?AF:71V46T&42@\MQT[')8[;+Q1WC!#+LZJ>W=$_,7>Z<'YI8S<S-::O+?
MWENVLX(J.6J?DF?['>AVX?J]3_4.L[")HD/!XRA]$!,?F>IUY0?V-+YZ?!<T
M$<,4,E1%65%%:1%D5XYR^UN@;^Q+^4M]3W+1.;FRO! 23QU)2DW#-TEAF9B<
M<?%.)M<YSI'&S??LJJVN*F;/6.U>DJB)(/CLRH.[#WOD*@6S!"G8[-R^$7!R
M[8G#S=3S^.:7CU,+9/^N>H;-,.":V5G4N_'U=M2.CK"<FYN!:069%[X(]=^)
M(E=6!'4C451*VD.+39"6T#8G43NRM9:"9P@7$3X8& "U,ITFD9J*)>J''UZ'
M1DL*RQQV'C']14B>(UWXQRHKBT\?;_W2ZP>_]L[1-T_MW=-2 R,D< !&XKLM
M"&>UBYFFZ(*98@ !GDT-%0?VU#-@"#$_C8]/DW0*6*#XA_8UO79R-WGI9"Q"
M"IFULV;:%/1_P?S^\8M7VRA9AJ(#V_'1!,)R6 S*L^YJJ0*>//W^X[Z__OE5
M4G&IBBV] QR[4;^'PV/Y%P\#4D)!0>Z^W77?^NKQK[YUF AI,$2#()P4YC$^
MA$>P/:3ZW.H:^ARZ#O5#'7_PNT8O2"LJH/)I05%ACMA%\ZDX9ZL!QUHD9PMG
M&ZHPT02R6\S?)#]'=&+/*PVB8KE=7$*3.WJPI:ZZ'/":5F 8Q8X@BQ8MAU "
M#(PV:2\[FH5--)5?>/L(5=THJ[$^E_ZI7(<;PC/>>^O(H?U-Q<4$C!#JDJF)
MTMD2]I++1ZD_RU__4>J.ZT?]AK]R3E9.KGQO9_*7&C]HMZ);&@G050JHOUG8
ML'2)A2V>)<KD64$,SFP'%)T78F&+<9VA<;C=O8=]&]H;.?,+:&';7C1!,-O-
MWB -8>2AIL#=H3EZM4WA4<A*/U"9>Z@J#R]+5KI9A6T[47J$MM-K%)[A*CKK
MM%;E85A[95_YJSL*#U02LAPUQ(7+'(_"BBR]1VV'R1&T@-?@$Z)A#Z408&;[
M*G)+<C(F%Y;O#\^22'1M8 :ODFPCKWQC@R'ZH+HP^_B.XK?VE[^]O^SHCJ*B
MW P-&PTT] W83 0L,:1<#RZA0V)YSX+>P38<FXFR'.4NRF#6'YPO!P8ZD!BI
M;<^N.O,JNRUL1-CL/CI>0"QU_JEJ(\"6^&$4"^0C8MM0>O1LG7\X)QD_-T2^
MP\*.[(EU#LO2D0,[,%@A:(L7)%?-.\[-)?] UK&VH7M!IL%U(G?1,Q YWWG]
M(&8E#.*X6 B$=84HG&?:T4H^,3;X'Z.B\IN.2D:#H@;Y0[REYH?$VDJTE4W/
MJ%48$<=S<9F0*4F6_INO[,.P0&8[XP=0&!:D(&7$)&(WX0OQ &5GP>30.W<U
M5^&VP7[%9-]\90^.DP-[Z]%L*!^'9?R4E!4A[3Y_XX+9$3[MH@IBJR[3I&0J
MY.EAQ\!G5QY^>N'!]=N=1'Y3H31B]#$J[/[ TBDE+C6##^YX\_1>CF,'=E"O
M$R)(?$3"51MMR;6\W"PD_9:&*B9(P0+GM7(+[?84/ F[XJ/'_4241<5DS9 =
M)3,4RYJ$3'O.J-*)1QE=A,C6D>I'L&KB/O WD 0:1+*)1$,RW#31:X-412*Z
M4GF_6WUC/%!T8A^0I?#$5)4748SUJ01GPQ,4%=- 3CM8+ZM%ZP_[)N'+3*EV
ME)F1F46GI0QT/BS1PGLT/E./3-PB7*4PW&1WZW2BDJ]'LR?3BF>;Y=_AJUX,
MUS%A1A@)I6N65B;F%CO&Y[O&%^865TJRTP@M.UZ33Y-0CY\B)D+EL7'A=QF:
M6R).FC;5;^TJ_<VWF_Z[KS3_Z]?KOK6GA"ZBNOLL9,:Q!'\'BPOR^TYQP"&"
MC<3%YJH!1_-%>$-@],[2K!-U>6_L*#Y65X#9;6AVZ</.R0\ZQ Q(RQ5+=.%&
M&D6=OK\Z[[=.U?S/[S5Q?/=8155^AA@93,@S;X<:H2PL9R,4"%'3I%=G2W)4
M4Q_FG6HV/SV4L=F]0P(4N[__WNU]S0J4C:1^5V%G3B+U$-'(*9P.$I>E:1F0
M!JF\POY'#YN;0PES"=<*. F5LJ KQ/^W7MW_BU\]^>X;!S&O:>EE9^,T'F4O
M<T!$IA!.%]L48<J8XW[UFZ=_[1^]<N)0,T0S6Y0M"PESV]1FS0&!>_"H_\$C
M%\O+S4$GA#A$R('!B?%QC9-6_X'?^4Q9GLPCB;9X[XW#O_+UTU]Z[>#!W?5(
MEQX-O)CCV)4WZWF]0B5L8V3RALB+@WL:OOS&H?_F6V=^_1?/H#;!=-]]':XI
MTK>=*'&;X54!'@9K:&Q#U\+I09P/S&?P2?SL++4:+^&90/G0DV28ZJ-RH=)R
M%YTA)5@(Y3IZL.G7_M&KO_+U5_:TU*&+P#Y=,0G591.R7",X([-%-L><B"&Q
MK*PP#]>H6.2"T8JFQ_G$,3]Z/!!P=#>OM939V86N[F&2526^V<U7MJ(NFC%]
M'U6L.IGM H5-"KD]7-C9,SBKW$6^5ZPCX;2S>Y!P><FR<G!W@&(P<%-,6(UU
MI91T@\I#X+TT%&RO1%;K+"[Q[8>R-4[MI;%)G@+^2&<_3-!Z\%D.)#!:0\FQ
MO+@@[CVKI&Z'=2PT=##Y.$*%-F4YWL^]$=OQ6SXZS$VCT?X.<Y.M#OW9N$Y$
MN$E8[^75D=FE_JFEH9DENNG@FZ0_&^'(3279N$0<\)5,3"VND+#Y6>?D1_=&
MK[2/C\TL%>=EX+1_:T_9F::BO95Y6,,2)O%, D.()6 Q::K-I3FG&PI.U!74
M%&1B,^B<7+@[-/MH9)X";I3;,1J!4(R#'/7H>'W!20FZ$QWBP>#<[?[9<0*H
M WWG:0.*8&AP:KAMB.PBL U)$Q._=*RA;\THK6OTX,WH--36#OOHO^%,.0@Y
MXR=,%E@_VCH&:'Y#M1+O]PJHF9()J5\HS@DSRV@<T3SUT+#(D9W#MG16$Z%B
M;LA(A9CFFYNJJ!R%+X$ ,.(=:+49\G^W-B%GC2^6,1X:8:6A9T#X]N^N.WV,
M_)(]B.UX4)#B [$ZZN*V3$-J7TY(N2^I>X9;OV]H@HP67 *\IVFC"1O&]NR=
MT-;*XGVM]:@IF"MWMXB_5R5E/74#V <K([_%ES$51Y08)%MJT6]0T=XY<X#;
MXB% K;2BEI&91EBM8VF.83A45S#X"VA'MDBH I%X6#4U-]/T-G<3)\GH5Z:$
MP;!QX1!A\=JI/3!"#)66$>4'D/CT=9M>X@4P5*+M$::%AFKE^!P*>O\:>:!4
M#P/F8!1#TCPD>4G5G%XXA\5,^[WKKK;U]6@6(H.;#W8PRNUP>*XC'7I -A0@
MBE" \)04LLNCGEHTL^:&BIU-E25%N9N%*"<@7"(7TI%0.9!:$N<N/B#.'IV2
M0N!G+]SC(!U*_][_Y.(]*L;*H5_*-_KW8]QLEQ]>N=4N6=6SU/Y)V.&;LIP0
M\NNN$8!'323K%NFYO]AL#S[WC3^W&VS=KZ,"B^H=D0PQIVXX:3]5TCP?CBQ<
MZY^]VC\#7RDOR#I8G4>T6$NI>E0"#TU**KUVOG]_[*]O#GUX;>!Q[TP:G4-S
M,N *93D4(<9C;_X?V8"!GJ#;TJ)9S:X3X$0BW!.)2J )H<6GI9;DI"/)M(_/
MXTS"B4LO@Q(-D*,2*,$.X6U5VQB87#S[>/+G#R;>;YOHGUIL*LVI*I0>%7[/
M;:9LR] EPN16.]9>[]>Q9;1II6+QD'R7?!J@%4!>82UDV!D[&1V;Q=P_-&;?
MN"^I2N(_SK"!1\=GR-*GK,CUVQWO?W+[TM4VL@MIL^9<3O8,4YM24H@+0F#?
ML[,.-S@VJ_[A\5L/NBE%0T\:TZU4='7PYI_BPAS*ZV)BPIVS?U>=>3(\O!U'
M":'O!<XG;TJZKA"5 -WLZ!F$X4D9,RD4$,:>R7!%(E[&KD@;DIKJ$H@FEL#;
M]WMP/M]]V*U16,8G@A65V4&=C^YOIBPC<VS=487I+W#UV\3\R)TVHT@<N4=(
M-!UJBQ8 G]9<Q?KJ,F+AL!EJWV+=!%XKTNN,[KFI8Y(BZ$NC":2\J1^FPE:2
MLFAU+ WH@DXY?E]K4(6[BTQ1(M:RLPA40]]Z[\W#F"N9E ;?^>E[9BES<=3?
MA',YP?M9#0FD#RP=8*'%8!<F2K=PQKY5G2!%""3<V\H\Q:XE25<I*1V]PS\[
M>^O:G4Z:=J)BNO'9?E3TE^>:SN.QVKU92R5$%W,49CWB3;"8<1)/)][]VNU.
M0A!A<DX<B&[BE-6:ZN(S)W:=/-R"I93"U7ZGA//BR51]A6_!SRA32S&WP-[A
M(2G_ F&$J@>/^Z[>[& Y"-3\3%R8#ZU0+&\^N_+(?Y3O]80'_'3NTGTZ)#UL
M[\<-6UM9*JJMSLYY <.)1I\F[UTT0?<0,I-&3L>XH45.$Z\?C9S>4$M+N&^
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M>&CX>A8"I$L4%P*><U(;7N[P,!I-\'D\YOGON66ND\@%G,P;R %8W:F9.TO
MR^HJ,6O%V6D4(X"LD^/@S.>$Y<"9YC#!+8XM+H_B!)I8'*$#_;)$(AG+<0^Q
M?U3>#/3<<.5CANVM0B JICLZO;9*[35J@U;FDP.>AOI"71Q*94.^O-U99 :,
M3!3U*2+Y7WRD%+%>GI8.;X[D^QVR[7T2TQK\7I1YN]@B#XJ0WKG-;Q-Q@3UF
MBPOU +>EU7M<1$[[MW_A).7("%/6S6[>H]2,]/3<O$QBQM6KS _F8W!N%>-
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MHC5LI'>GV? %4-F9$$TJC+&E:?=I!#R0?U0L,30)%S6Z)X$WS !AG-_I1T
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M*4EJ/2^/UB:?M $$! &):4+,QYF!;X9$4<@FEC127J[?Z80VH>Y,3,]V]8W
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A\DE)""0AD(1 $@+_?V=^N>D[9%*(     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>rmti-20210331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rmti-20210331.xsd" xlink:type="simple"/>
    <context id="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001041024</identifier>
        </entity>
        <period>
            <startDate>2021-03-31</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl80L2ZyYWc6OGMyZjFjMjgxNThkNDgxNWIwYmEzMDQ3ZGRmYzYzMDkvdGFibGU6YjY5YTI0OTVlY2NiNGZkZTkzZDk0MDkzYTI5NTEzYzIvdGFibGVyYW5nZTpiNjlhMjQ5NWVjY2I0ZmRlOTNkOTQwOTNhMjk1MTNjMl8xLTEtMS0xLTA_7709aed5-fb43-43cc-89f3-ce4ffd45333e">0001041024</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl80L2ZyYWc6OGMyZjFjMjgxNThkNDgxNWIwYmEzMDQ3ZGRmYzYzMDkvdGFibGU6YjY5YTI0OTVlY2NiNGZkZTkzZDk0MDkzYTI5NTEzYzIvdGFibGVyYW5nZTpiNjlhMjQ5NWVjY2I0ZmRlOTNkOTQwOTNhMjk1MTNjMl8yLTEtMS0xLTA_555c5d13-3afb-4e54-a76f-65b314d111c0">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGV4dHJlZ2lvbjo3ZDM3M2MxYzQyNDE0MjVhYTY0MmQ1ZTAwYmI2YzBjNl8yNjM2_84c2bc01-6867-481a-bf2b-1c859f4ae089">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGV4dHJlZ2lvbjo3ZDM3M2MxYzQyNDE0MjVhYTY0MmQ1ZTAwYmI2YzBjNl8yMzc_2f19c88c-a8cf-4b5d-9900-6123e2a70a7d">2021-03-31</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGV4dHJlZ2lvbjo3ZDM3M2MxYzQyNDE0MjVhYTY0MmQ1ZTAwYmI2YzBjNl8yNjMx_05ce7b0d-d246-4e72-b223-58613458bed0">ROCKWELL MEDICAL,&#160;INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGFibGU6NmY2OGIxMjQwNzdhNGVmMGJiZmM1N2ExMzg3MDkwMzIvdGFibGVyYW5nZTo2ZjY4YjEyNDA3N2E0ZWYwYmJmYzU3YTEzODcwOTAzMl8wLTAtMS0xLTA_cb00a963-537e-4736-a2e5-12f1e9070463">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGFibGU6NmY2OGIxMjQwNzdhNGVmMGJiZmM1N2ExMzg3MDkwMzIvdGFibGVyYW5nZTo2ZjY4YjEyNDA3N2E0ZWYwYmJmYzU3YTEzODcwOTAzMl8wLTEtMS0xLTA_ab00d533-5157-41f5-a0c3-14941fbe264f">000-23661</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGFibGU6NmY2OGIxMjQwNzdhNGVmMGJiZmM1N2ExMzg3MDkwMzIvdGFibGVyYW5nZTo2ZjY4YjEyNDA3N2E0ZWYwYmJmYzU3YTEzODcwOTAzMl8wLTItMS0xLTA_6fe8d4ab-1d81-4013-b7de-dce859879dae">38-3317208</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGV4dHJlZ2lvbjo3ZDM3M2MxYzQyNDE0MjVhYTY0MmQ1ZTAwYmI2YzBjNl8yNjMy_613cbb4c-1fff-4ccf-986d-1a1b2106c20a">30142 S. Wixom Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGV4dHJlZ2lvbjo3ZDM3M2MxYzQyNDE0MjVhYTY0MmQ1ZTAwYmI2YzBjNl8yNjI3_1d69d2be-482b-4618-839f-e4a7d9a8db76">Wixom</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGV4dHJlZ2lvbjo3ZDM3M2MxYzQyNDE0MjVhYTY0MmQ1ZTAwYmI2YzBjNl8yNjI1_83b639df-2290-4318-9fde-62e5258d7116">MI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGV4dHJlZ2lvbjo3ZDM3M2MxYzQyNDE0MjVhYTY0MmQ1ZTAwYmI2YzBjNl8yNjI4_d9c98528-ec0a-4d89-b59b-c142e45457dc">48393</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGV4dHJlZ2lvbjo3ZDM3M2MxYzQyNDE0MjVhYTY0MmQ1ZTAwYmI2YzBjNl8yNjI5_be9072bb-46dd-485f-a53f-2fa9dab8abe9">248</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGV4dHJlZ2lvbjo3ZDM3M2MxYzQyNDE0MjVhYTY0MmQ1ZTAwYmI2YzBjNl8yNjM3_cbd0da74-6cc5-4e8e-836e-1df8063b841d">960-9009</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGFibGU6MGM5MTgyMDY3OGNiNDdkNjk3NGVmZjRkMTU4MGJiMTcvdGFibGVyYW5nZTowYzkxODIwNjc4Y2I0N2Q2OTc0ZWZmNGQxNTgwYmIxN18wLTEtMS0xLTA_37b425ca-8f5c-4cfb-8ff1-a284ea98f645">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGFibGU6MTIzNmYzYjc3YzVlNGVlNzkxZDZmN2EwMWJkNTAwZmQvdGFibGVyYW5nZToxMjM2ZjNiNzdjNWU0ZWU3OTFkNmY3YTAxYmQ1MDBmZF8wLTEtMS0xLTA_e7c74183-a0cb-4eaa-9c99-8b7b0c961117">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGFibGU6NjMxZmEwMWU3MWNjNDQ1NmExZmFiNThiMTFkZGE2NDMvdGFibGVyYW5nZTo2MzFmYTAxZTcxY2M0NDU2YTFmYWI1OGIxMWRkYTY0M18wLTEtMS0xLTA_5bbeb185-891b-4fe2-a259-6ad61244bd8e">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGFibGU6MjQ5M2E5YmFmYzgxNDI5MWExZWNmNjA4MTgxYTM0OGUvdGFibGVyYW5nZToyNDkzYTliYWZjODE0MjkxYTFlY2Y2MDgxODFhMzQ4ZV8wLTEtMS0xLTA_ae914c1e-c6fe-4e13-b0c6-24647df4e58d">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGFibGU6NzRjMTZjOTUzYThmNDY2NGJhNDBjZGEyNzczMzVjNmEvdGFibGVyYW5nZTo3NGMxNmM5NTNhOGY0NjY0YmE0MGNkYTI3NzMzNWM2YV8xLTAtMS0xLTA_ff86f458-7f83-4678-8fb3-03d36cd27003">Common Stock, par value $0.0001</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGFibGU6NzRjMTZjOTUzYThmNDY2NGJhNDBjZGEyNzczMzVjNmEvdGFibGVyYW5nZTo3NGMxNmM5NTNhOGY0NjY0YmE0MGNkYTI3NzMzNWM2YV8xLTItMS0xLTA_5a202a31-c98e-4447-922f-e406a2dee93b">RMTI</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGFibGU6NzRjMTZjOTUzYThmNDY2NGJhNDBjZGEyNzczMzVjNmEvdGFibGVyYW5nZTo3NGMxNmM5NTNhOGY0NjY0YmE0MGNkYTI3NzMzNWM2YV8xLTQtMS0xLTA_ef23835b-6c23-4fb6-b70f-0c9ee0c3f3c0">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmJlMmU2ZWE5YjM1NDRlYjQ4NWZlMGU2NDI0ZTcxZGYyL3NlYzpiZTJlNmVhOWIzNTQ0ZWI0ODVmZTBlNjQyNGU3MWRmMl8xL2ZyYWc6N2QzNzNjMWM0MjQxNDI1YWE2NDJkNWUwMGJiNmMwYzYvdGV4dHJlZ2lvbjo3ZDM3M2MxYzQyNDE0MjVhYTY0MmQ1ZTAwYmI2YzBjNl8yNjM1_17a20442-2f43-4afb-90a3-3504d9bc5e19">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139885399273224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ROCKWELL MEDICAL,&#160;INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-23661<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">38-3317208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">30142 S. Wixom Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Wixom<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">48393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">960-9009<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RMTI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001041024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M&52G$==\&F-HI;-[N#?_'VVB4L,B\I=(3OI C6*KXW=]C*TT? _WZ7S\!K!
M.HV""] 6-LN\TMT]W)8?50 YF:R4Q&RI1J3;=B^[KMO%B$HG]W"W?=/"&"XA
M,7&<R;TII954N-""12DZ^TKK]G#?G:I(!,((N21/4-Y:L*B2!U>IY2FMV\.=
M=J+Y90#IX3"_=HL7+D-8&;TL%B?&#]>K)2M=V^M^CFR<IAF0U0+BLG6 M'1]
MBEOT3!CX *L%\>A/\Y_)E <9U-NVBJE&R=8G?"VG1@7O%R1AFGRP*./D![<)
MWVETN5O:/L5]>J99:*MNNHWGJK+F:@1>GV:8F=*CE3?NR8=$D=$F6#&YY">7
M@35"SX/IW>!WC*DT>'J6P8]BKI<V2[^"@EE9XTB8K!Y27+"VS$I_I[@][]&&
M, 4T^.L8JG]#'G@U%"YEB\EM>2YM862EX5/<JP<P+<-\:MY';%G)@PN<3))S
MM+^T>W78B\"PI"3B"Q!RF]>@JW?;WUW#J"3?<LZ5@0UL?KKB#'S"/@#W%TJ9
M0\/N8HL_(?K_ E!+ P04    " !O@7]2GZ ;\+$"  #B#   #0   'AL+W-T
M>6QE<RYX;6S=5VUKVS 0_BM"/V!N8FKBD1BV0&&PC4+S85^56'8$>O%DN7/Z
MZZ>S;"=I=67=A['-H<G=/;J[1W<GF:Y;=Y+\X<BY([V2NMW0HW/-^R1I#T>N
M6/O.-%Q[I#)6,>=56R=M8SDK6W!2,EG>W&2)8D+38JT[=:=<2PZFTVY#;VA2
MK"NCSY:4!H-?RA0GCTQNZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ?$,78&F? KP(
M&K <XRBAC05C$C*$[_VX_!DP::U7A90SP24-AF+=,.>XU7=>&18/QA<0&>7=
MJ?$,:\M.B^4M/3L,/S[)WMB2VSG-@DZF8BUY!72LJ(_PZTR3 .B<45XH!:N-
M9@.'R6,4?-@#E_(!6OBMNHK=5R3TXE,);2"PU4GTA$8QA D*Q+^,%F)?A+W]
MK;"D$8_&?>S\;O2@?^^,X_>65Z(?]+Z:\V/1%WATUC3R]$&*6BL>]O[+"8LU
MF_S(T5CQY+/!I!R\@5M*'KEUXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M<\TUMTQ>
MDO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9 ]IV03NA1.XJRY/K%.?7A
M'=O["_PJOE]?\HIUTNUF<$//\A=>BD[E\ZI[J,NXZBQ_AOMHD<VWL,\E=,E[
M7FY'U=;[021>\%G'!QR>(W?#$T<PGX#%$<"P/!@#S"=X87G^I_VLT/T$#..V
MBB(KU&>%^@2O&+(=/EB>N$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/AG$##RP/
M9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q _G@>
MF*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%'
M, ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04    " !O@7]2EXJ[',     3
M @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/
MV!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"
MKM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%"
M:4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0
MT^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( &^!?U*J
MQ"(6,P$  "("   /    >&PO=V]R:V)O;VLN>&ULC5'1;L(P#/R5*A^P%K0A
M#5%>0-N0I@V-B??0NM0BB2O'A8VOG]NJ&M)>]I3<V;K<7187XM.!Z)1\>1=B
M;FJ19IZFL:C!VWA'#02=5,3>BD(^IK%AL&6L <2[=)IEL]1;#&:Y&+6VG-X"
M$B@$*2C9$7N$2_R==S Y8\0#.I3OW/1W!R;Q&-#C%<K<9":)-5U>B/%*0:S;
M%4S.Y68R#/; @L4?>M>9_+2'V#-B#Q]6C>1FEJE@A1REW^CUK7H\@RX/J!5Z
M0B? :ROPS-0V&(Z=C*9(;V+T/8SG4.*<_U,C5146L*:B]1!DZ)'!=09#K+&)
M)@G60VY6= ;N\N@#FW+()FKJIBF>HPYX4P[V1D\E5!B@?%.9J+SV4VPYZ8Y>
M9WK_,'G4'EKG5LJ]AU>RY1AQ_)[E#U!+ P04    " !O@7]2)!Z;HJT   #X
M 0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( &^!?U+^6ZQI[0   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( &^!
M?U*97)PC$ 8  )PG   3              "  <L!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ ;X%_4AJQ@=1#!   D!   !@
M ("!# @  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( &^!
M?U*?H!OPL0(  .(,   -              "  84,  !X;"]S='EL97,N>&UL
M4$L! A0#%     @ ;X%_4I>*NQS     $P(   L              ( !80\
M %]R96QS+RYR96QS4$L! A0#%     @ ;X%_4JK$(A8S 0  (@(   \
M         ( !2A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( &^!?U(D
M'INBK0   /@!   :              "  :H1  !X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<U!+ 0(4 Q0    ( &^!?U)ED'F2&0$  ,\#   3
M      "  8\2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(
' -D3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="rmti-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rockwellmed.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="rmti-20210331.htm">rmti-20210331.htm</File>
    <File>rmti-202012312020xearnings.htm</File>
    <File>rmti-20210331.xsd</File>
    <File>rmti-20210331_cal.xml</File>
    <File>rmti-20210331_def.xml</File>
    <File>rmti-20210331_lab.xml</File>
    <File>rmti-20210331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "rmti-20210331.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "rmti-20210331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "rmti-20210331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "rmti-20210331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rmti-20210331_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rmti-20210331_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "rmti-20210331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 28,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "rmti",
   "nsuri": "http://rockwellmed.com/20210331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmti-20210331.htm",
      "contextRef": "i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://rockwellmed.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmti-20210331.htm",
      "contextRef": "i5d7db4d153634a65b74597e75d0d1a99_D20210331-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]",
        "terseLabel": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]",
        "terseLabel": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Addresses [Line Items]",
        "terseLabel": "Entity Addresses [Line Items]"
       }
      }
     },
     "localname": "EntityAddressesLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesTable": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container of address information for the entity",
        "label": "Entity Addresses [Table]",
        "terseLabel": "Entity Addresses [Table]"
       }
      }
     },
     "localname": "EntityAddressesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_FormerAddressMember": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former address for entity",
        "label": "Former Address [Member]",
        "terseLabel": "Former Address"
       }
      }
     },
     "localname": "FormerAddressMember",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Forms 8-K, 10-Q",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "308"
  },
  "r6": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001628280-21-006255-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-21-006255-xbrl.zip
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MV0F[\RY\'E[2YH'O-$^T[J"K=FV@;9\&7<GRK69OV+.'\UY]*$*^.:2IEMV
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M^"JMDM-.EAD6708,EO)RT"K>01]*<NE&PQ=-D4:9D,:!3X7E$(X(I=#1-5'
M.97K:BIY7SR+C(@W9$2Y4T;^_1?6Q'>/%N6[T.@%SH"#=L=<M/#I+.VE!USX
M$,]I;TV7]I8E'<VM.=@W9Z8(=M 4Z.+N60/H?QI:9R<3L_G)MT)S C87V$ZG
M"OW[4]"3@DMG$,N]NBF;DCGMSH%VO0'E3_M=NRN:X1'NV7M@L[6D[OSCP +;
M"6J0SG7%E1P7G#Y-UZI(T3%!CB<Y"+NZ:G@*8:)NE'9U]/FFR20\H_P\Z>QX
M.C;O%G/05)V&90N=QI=VQW[Q['X9)^F81)F0Q<(Q<[GW7G0TEH4X$;#ZAKXM
M?HB]%]^8K,]X(\:)G_E M3%U^V#J,V'/S838$[ A*[?:L-6K6[WZ,MCD/A 7
MTPX;Q4DFO%E^9P2\()9F KODL=TD3V;T;>T*LY]CKCV1*E^-JE#H@! H]BF9
MS: 76'27JO^2>XN-PH?\PW2^.7?/)0\;KJZ[B.BNAQ1'I<@ F$ :EF0FD:I(
MJK2T:Y+$[0LRWLEC_5OM_T1&[I,'D3OLPD]YM#VS(.4/$W>H87HNJBZK.B)%
M5%(TI+"JA!Q)DI&J:UA65-UA5"SM=MK[G\\:AX>"V:BW]O<.=PH!:EG[Y<T3
M_C>-*0$3ALL"5PC)E0P()!72$7-YR(X*?B3X62J T0/Z(7G[XIOUG3F],*ZR
M>+0T7'ZKH688Y:I8_1$[3<;EJJ(\R$Y[%%FY+&I/0!:7=4-ZC%5YGPFY-!&E
MT90;B;>#G3<[O>COW^\LB$\"U2NF"X_]\@AXQD9)?,GG[;KM4F!Y*W+C!(RY
M?,WTF.?>C\=1ELSV8[J9T%ZL%EEA5VHW6U/(/['FM&\U3T.>KQ<"GU)C:LXO
M9+,^G)BW5HMBJ3?H*MU! U3!G@QY@<<NJ(!/87=^(G?MQKQ==R=M>V\./$X.
M[;VKU2+7$45B:* &Y"I#2E76$)&8BC"81\P0JZ*BR6!BLX!,P)"\O6"TP*#%
M#-@*]_?LD ,_8$#= >6Q%=3O"^KULB8!0:6J#(**U2I2L*<B(KHRPHH!7QPF
M:8J7+\TA2=:T6Y;Z5E(?*ZDVF;86RYINCK1;L7VPV+:NQ%;SF$X5XB!,=8P4
M$<O(J5*&J,MTU="K!B6LM"OK",:@*HGZ-^5V0^V(6U9L+L!O<LW-@Z5QUF>)
M,!@G?DK]/)2:K\R Q>ZO:OJW&SR'[^F"_3@,_91O2A2X8A"**?8*&]KJ' N-
M<!3$,Y;D@[L.+8(5E]_>%O5MA/37Q!R?7%?L49JP-%W\.00&\$;JB9\*L<S.
M-2R[CJ.X"'N>AQ37]9"A:Q1A@AWH.LV51 )@+V)%$H[+PID_C4-A[Y)%XUN6
M]8[PNP9M'SZV$SN>1'_<D+7D<TPU@TH.N#ZZY"!%PSK29<-#3"%5:A"=.E6M
MM)N/U&\8HD>[PHLQS%5I._D".?U\!_*?-I#X7)<=33:HAR3)$)$BPT :'AA:
M&GBSDJK3*L8PD*;O]OT+$MV.9?ZFV?8EAC$->OYH8V,5/S5.RCDU7$-7)1TQ
M5R1(H;J!'-5PD N@R!154:O4+>TJ, GE#0PX+T:91YM'"4Q%?T0"@4V9.\[\
M2QZ$!HN'I3O<L W&W( 3YOX(I(VRC0\[OQ1CY\T33F6N*_<21O[,R:N>.SPD
M*#E<45**^/9@1%09,-<CX,@Z.H$,I5U)N>7&OGU*@#V,P<WYTH^C38ZL_93I
M*9^[#O05J2I(<UT5*4QG8,=H#&'JZ:(F.[J":6G7T$1DB**Q@<AZO8#[[[]T
M"5??I4+& C;BPRY$^;BOPBJ!6?J#N/KL^T(?AG-6G E[HU$ +C0XR2^(W7L&
M\ !L6Y8L%F.3W-2%KZ10F#!TGE#L.J-"RFU8(2#I<M/.X\9PNR_MC]B7]G!S
M9#!.,]^;/1.W^WWF#@6^Q9*,P)4#LY"'/9UX*C@LB"=<\'DBGQY%DW3T6?#\
M@*.8GP*D92RB,"NR&"9&. XR$K%XG 8S(269GWJSO/BB0.Q BXN06ES07=GT
M, 8Z,..BV3+-@\D03W@Y[F/Z/ Z9UN[8Z?D"K<UGWN0 CDI9%8N*[Y[UUY/J
M9F(U/R+UC2T'/YHH Q ]!6%%>@3+=R,5_A94W0E%CPY[!\R[/7#QZ.&S?@]F
M9B"<1#XW&P3S^.="WD\>&^)G9QT"$S@#+%DUA\\2/P/,X&L+XV@18$\WTB8N
MENW,IJF:]L7,K'?E=M/RK3H=6H.AS)?O>H/.T+1/%%[.M-V;RW9 9SAMUUL3
M:^ J_! MU"^U;1=X[856$^JW+[@M/;7P^FJS7'44274)TCW518KK.?#)PXA(
MNL*(H7N:HG*,,JJ*\N[7KC4OM-6+6K]9B!2T9%6FA-'*(8C..& %9D/'+53-
MC7,%_#C!&UP5]@\Z@B2+9<CXD$6?+;9OL7V+[06V'X,-[\)LBBY,L")YHS89
MV&V@S^],&+AR=WX: * '%@!VKP[@+#4FYAF4M?<FO?#H)K!/S8$I]0:@#.9T
M /2!QQ.Y;1\,@9[<M?>FW? (F_6/8>]@'=A9U:TJ6)?YYB%^.P(AR' - ^E.
MU1%=0\,85_\@8+^6)R%<"-0]J(X5@K"T NQKI\2N8%T!KS7/^1*17<7X#T)V
M7=DB^^8@^Y>$<8N=7WR2'\3F3G_2]KP-#6<O=MP-S&DOY$C.Z5D#JWZ$K; !
MOQWXEMT'D_U@V&MR&N:M'7?F_"#D2,YY[TJF:-5/I*X-OYVU<+Z+[ZPSS$/B
M-TQWU7&8@W45Z08&A/>8!%:[:B"-4 U+BN)0G?U!" ]RA=P5P7J8#8\5BJ0W
MSN((\X- ORBPA?TM[&]A_X=AOY6F8Y:\#O#GEY>9$O 5 FC/+W@9U3P#\#^S
M0FNPIYCVQ;1KFV*[>7(3_&=6?CE:X'?/>H-VOOXYA+P'05<"55"_F+;K!WUS
M?J3T3F^<$F &5EP,D*=Y#,Q[OMU:=#4D*9I2I9["5)UNP?][X"]#U[UQ'P'^
MBP(/POX7M)CP/,RL1,2*Q1F6,+HV%.L7BESKX<6R#73_=I7FB8^BRF Q_/HS
MHU)9P<:OIRH!L]4-819Z5E/O+_IJC\W:_*;=Y30N_C:(VR\^[0<D37]._=QE
M43VK[KD!#9MWE.6><4P(Y[9HW?$L=.)@.W";,'#\WH_[YA];6#:+](7FG?1]
MM[^BHQ]S%F^AV[CFP_?NO7EI'?>;G*.5Y8S"%)IAR<GQ<8.]'6O>&9@V>"OV
M"7@N_="J=R6K^:EOU3\.>LW&S)J[<W-^.K#"QDUO1[::YA3HJ99M]=O-KF@-
MNF(W!*^G:0V[=DNVH*1U9DK=4WZW]_7A?<_3-4]1=53U=!DI6E5'NN?(2)2I
MK+E4@HD@EW:Y?QE'PG$6N\,=8402X9($8R;\;[YQ[1>?E-Y<--O.V(?,V(7Z
M*Q3?=KH^8+I>GP57"?0H@8YU#1T<9D6I(D.2^%DS42,29<R0G=)NQ[1;VSFY
MG9./#3%R&^;V,<&EAEW&;C;V]K/?/6V/KK<,>)*LRZJ#-%<"+>LY&G*JHH=$
MUV!,=&5/Y@\J6"2EY!^A&<0."023)$.6??\RAY<='WMQ>ZE;$>6Q2R8X,\'-
M]U6'T-'"I,_R*R1N['?V4P%89-#W%WR#PT423[(^#X&.^!YHD@J4>5!%?@'<
MRO8U45WNC[ZQ=ZVX"E<6WO",U7?Y%K9E9C^_/V[$[X_CIQM6@JF2@Z0["-YU
MR>X591Y3O2ZW0KN\&7&_%8')'\IZ)G%IW#WTZ\S_[@6GI[F1X<$+3L5IY&7/
M-/..V2_Z92/UPD^=F\/GN I&F:)(2/+X\TC\R1Q#)#*255&AAN.J#!OW+AC=
M?VSNQG,HHSCU>42_EK" \)/ MQY(N;9X\O"V>%V$.&#VC+/;1;[WIDKQ?S^Y
MMA O&'(21H:(>  F-1),R"PM59[@,9>7CDK/K,:\;R@F?HKQ3BWGWSK0TP<=
MQ@+F\B<+HSA?.AJG+,\%35T<&^(OS.62)!3O W&HR.L*9KSR_*E#K@\C:!ND
M).S23Z$<:$82N1SSB.ORZQ5Y9O[ '24)38L#0_2;ZU;R&[*^;K6J\LJ/O83[
MU^+OU83>!&WZS*MH?\ )QP<=_-UB^C<ZZ3G.0!<>/V7NXH*X6KY5@><"B,W8
MXCBE5!:EY[_P_^'_/Q^OW^K/#DO'099?;-(&/;+8/P+:0#BX4A3[,2@NGG"?
ME_),LO/]4\2K_[<C8?W2_QVHS1U.6 !N/>.:.=@16I%;!O\R'8,&)* ,^9TO
M@ .,@/KEG<)($@'VI'D2B[+B2"Z)(M"D;GZR%_KR6L4FB][EJIEKRG_&^57D
M.2G^@H-0Z/(Z<QF_Z&#)FE@6]@ 91U<'>M<9 ;_1&P,?:9]SR5W.ON_XF6 8
M9<S5=>Y9[H^3A.\,6KR>P6\B!%="T/DM"Z+Q[O,+&\L?QP&CS-<ZMCCP<_UY
M/=OS.\?XIK("!A;"E;XP>;GG,HKEXTQ+KA\[./;:Z7FVF%@PG1S&?[B>=GV6
M,&YBW[=A:R,N&_F60#2^_MWZV+*7ST34&U]?R!B_;*/:P&5)TG_$IM;+6E7]
MY=NR<-EX@J<7=*TLZD^]V>OW+6]]]RV;W)Q>8$HA?U9<_KG%N]^ZE/6@]FW:
M_J"'C5J=I6[BC_+;IW_#/I_-79-]E8UZS<.X"<CZP-9QSV5C1/1E3+MOV5^>
M]V1C]2V3\3U9\K+VUOO"BG[W[ P*_80OQ"5AYO,5-A%+,N9_ITNOOMS/POQP
M#3C;G<+9WA'XJXM4N/E>(+D937ME,Q*+RB.$]]<?&GS6QN_'P(WPA5PPH<7M
M&9!B?LMOG60D?\]A9[$LFQ5[#%H6)R%\_=@YS%WFXK;*]=@,%G'Y-GK?>R7?
M-B;]*ISHXU;3VK-/.HW-\)WO./68_^1'_%6/FJR-GFO'Q^JSW,5BZ3]C/UF$
MJ1ZV"6?GKE56.@YF@DO&?&4T#YL6%Y/R:APFI- 3D! 7[T@ZK$\"CR_><D+Y
M*"\R\&#0.((R.3DRSOIQ HVC&[*KY[E#)C]\FD_1RKKRZP_(R67U@0] /I)9
M27L],9-?XZEI+[Q1=\<4OOF8[NOTT/[L,,*&-^H5R2%_U+YVRQM[50/X<59[
ME8)922M%NSKC-.6K[HT@\-/'A64WJ;VO<A#_O,CK5EJWC7I1C=KO^\P#%W?Y
M^%0[?WPJ>? AI(W9#EEQ8CJ#/_TL#';_'U!+ P04    " !O@7]2.QC9THL"
M  !T"0  $0   ')M=&DM,C R,3 S,S$N>'-DW591;]HP$'[G5WAYGA,G(8Q$
MA4IK56D2VZ2N5?LVF?@"%HF=V4YA_WYV((/0=BW3'K9)2-CG[[OS=W>V<W:^
MJ4KT $IS*29>Z!,/@<@EXV(Q\6YOKO#8.Y\.!F=O,+Y_?SU#ES)O*A &72B@
M!AA:<[-$=PST"A5*5NA.JA5_H!A/6]*%K+\KOE@:%)$H/%Y569$.$R!Q@J,D
MHG@(=(1ISH8XA'<D32)"QRQYN\CB(4E82%+,1J,Q'A)"\#C.1S@A9!R%<Y+.
M[<0YW>A,YTNH*++"A,XV>N(MC:FS(%BOU_XZ]J5:!!$A87#_<?:EA7H[;,G%
MJH?>S%79X>/ +<^IA@ZN*L-_PI7,5VLHRPJ8G\LJ<&I)'(<>HL8H/F\,7$E5
M74)!F]),O$9\:VC)"P[,9KP$E],>X&#94+4 \XE6H&N:P\LQIP.$7"9X54ME
MD'C$/$A%F*9IL'':/+3-W$SFU+3M\&PJ6CQV0QQ&. []C69>\*JP?4=<:$-%
M#J?$MC/<\?[$'O9U/6T/'>_T/;3.-.3^0CX$#+AU&J:8A-CURU.;T,^1W #O
MV?WX5 AI6B_.LK/5-1>%W!JLR8G(.B774'3'YM%9>*)=VK^,JES)\H7>"FHE
M:U"&@SX\1ZV#I8)BXKG3A+L._EK2N6]WTD$>!>B7PRT'E@+E;*^DXYKOM>5J
M6XP2MKGYFX7GM#Q5N*7D3=G6^9^7SZ X5;ZE<,'_"_6U@E/56XJV3\?O5-_Q
M;^PZXFSB74C[$> A9[N]_O#L$]/&W&([9YV[?1VF]GD.[0_A_><"1BWK+#C&
M'GEI-+#/8MJ.C[7MR#O(+XA')^+5O'XK/4G;&;O<[2[6H'^S;N<'MV]KV%[L
MT\$/4$L#!!0    ( &^!?U)*$E_F@0$  ,0"   5    <FUT:2TR,#(Q,#,S
M,5]C86PN>&ULE5)-;]LP#+WG5VC>=;3DK]0VXA18A@$#LDNVHKTJ$A,+L:5
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MF;T3DG6I]D"Q%&XP!.N2V$:O]N<=D$M^Z/1MM,Q2(;.I\!DBC$1 $6,L<WX
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M_@?<Z#T,-,4?>#@XD&9U6#CT"UV'A_?Q3*\O6!10S'D(@2'0+M!-I$"D[(A
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M;G[H7_H_E+YX\G]02P$"% ,4    " !O@7]2'?@*WE4A  #&N   '@
M        @ $     <FUT:2TR,#(P,3(S,3(P,C!X96%R;FEN9W,N:'1M4$L!
M A0#%     @ ;X%_4K:@38>J%   ZYT  !$              ( !D2$  ')M
M=&DM,C R,3 S,S$N:'1M4$L! A0#%     @ ;X%_4CL8V=*+ @  = D  !$
M             ( !:C8  ')M=&DM,C R,3 S,S$N>'-D4$L! A0#%     @
M;X%_4DH27^:! 0  Q (  !4              ( !)#D  ')M=&DM,C R,3 S
M,S%?8V%L+GAM;%!+ 0(4 Q0    ( &^!?U+!3?+#: 0  , 8   5
M      "  =@Z  !R;71I+3(P,C$P,S,Q7V1E9BYX;6Q02P$"% ,4    " !O
M@7]2))*#9C@,   9<@  %0              @ %S/P  <FUT:2TR,#(Q,#,S
M,5]L86(N>&UL4$L! A0#%     @ ;X%_4B_#Q8RF!P  'CP  !4
M     ( !WDL  ')M=&DM,C R,3 S,S%?<')E+GAM;%!+!08     !P ' -8!
(  "W4P     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
